
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Profiling with senescence-associated secretory phenotype score identifies GDC-0879 as a small molecule sensitizing glioblastoma to anti-PD1 - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7131F89B72E431C131F003681AB7A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cddis">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334699/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cell Death &amp; Disease">
<meta name="citation_title" content="Profiling with senescence-associated secretory phenotype score identifies GDC-0879 as a small molecule sensitizing glioblastoma to anti-PD1">
<meta name="citation_author" content="Yang Liu">
<meta name="citation_author_institution" content="Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning China">
<meta name="citation_author_institution" content="Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning China">
<meta name="citation_author" content="Yuan Feng">
<meta name="citation_author_institution" content="Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning China">
<meta name="citation_author" content="Lin Cheng">
<meta name="citation_author_institution" content="Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning China">
<meta name="citation_author" content="Yangxi Xu">
<meta name="citation_author_institution" content="Department of Neurosurgery, the People’s Hospital of Liaoning Province, Shenyang, Liaoning China">
<meta name="citation_author" content="Anhua Wu">
<meta name="citation_author_institution" content="Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning China">
<meta name="citation_author_institution" content="Institute of Health Sciences, China Medical University, Shenyang, Liaoning China">
<meta name="citation_author" content="Peng Cheng">
<meta name="citation_author_institution" content="Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning China">
<meta name="citation_author_institution" content="Institute of Health Sciences, China Medical University, Shenyang, Liaoning China">
<meta name="citation_publication_date" content="2025 Aug 9">
<meta name="citation_volume" content="16">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="602">
<meta name="citation_doi" content="10.1038/s41419-025-07915-3">
<meta name="citation_pmid" content="40781221">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334699/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334699/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334699/pdf/41419_2025_Article_7915.pdf">
<meta name="description" content="Senescence-associated secretory phenotype (SASP) in cancer refers to the bioactive secretome produced by senescence cells in the tumor microenvironment, which could be triggered by therapeutics or local stress conditions. Here, we provided a SASP ...">
<meta name="og:title" content="Profiling with senescence-associated secretory phenotype score identifies GDC-0879 as a small molecule sensitizing glioblastoma to anti-PD1">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Senescence-associated secretory phenotype (SASP) in cancer refers to the bioactive secretome produced by senescence cells in the tumor microenvironment, which could be triggered by therapeutics or local stress conditions. Here, we provided a SASP ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334699/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12334699">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41419-025-07915-3"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41419_2025_Article_7915.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334699%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12334699/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12334699/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334699/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cddis.gif" alt="Cell Death &amp; Disease logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cell Death &amp; Disease" title="Link to Cell Death &amp; Disease" shape="default" href="http://www.nature.com/cddis/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cell Death Dis</button></div>. 2025 Aug 9;16(1):602. doi: <a href="https://doi.org/10.1038/s41419-025-07915-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41419-025-07915-3</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cell%20Death%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell%20Death%20Dis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cell%20Death%20Dis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cell%20Death%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Profiling with senescence-associated secretory phenotype score identifies GDC-0879 as a small molecule sensitizing glioblastoma to anti-PD1</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yang Liu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yang Liu</span></h3>
<div class="p">
<sup>1</sup>Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning China </div>
<div class="p">
<sup>2</sup>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yang Liu</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feng%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yuan Feng</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yuan Feng</span></h3>
<div class="p">
<sup>2</sup>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feng%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuan Feng</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Lin Cheng</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Lin Cheng</span></h3>
<div class="p">
<sup>1</sup>Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lin Cheng</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yangxi Xu</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yangxi Xu</span></h3>
<div class="p">
<sup>3</sup>Department of Neurosurgery, the People’s Hospital of Liaoning Province, Shenyang, Liaoning China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yangxi Xu</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Anhua Wu</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Anhua Wu</span></h3>
<div class="p">
<sup>2</sup>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning China </div>
<div class="p">
<sup>4</sup>Institute of Health Sciences, China Medical University, Shenyang, Liaoning China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anhua Wu</span></a>
</div>
</div>
<sup>2,</sup><sup>4,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Peng Cheng</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Peng Cheng</span></h3>
<div class="p">
<sup>1</sup>Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning China </div>
<div class="p">
<sup>4</sup>Institute of Health Sciences, China Medical University, Shenyang, Liaoning China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peng Cheng</span></a>
</div>
</div>
<sup>1,</sup><sup>4,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning China </div>
<div id="Aff2">
<sup>2</sup>Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning China </div>
<div id="Aff3">
<sup>3</sup>Department of Neurosurgery, the People’s Hospital of Liaoning Province, Shenyang, Liaoning China </div>
<div id="Aff4">
<sup>4</sup>Institute of Health Sciences, China Medical University, Shenyang, Liaoning China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 7; Revised 2025 Jun 30; Accepted 2025 Jul 29; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12334699  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40781221/" class="usa-link">40781221</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Senescence-associated secretory phenotype (SASP) in cancer refers to the bioactive secretome produced by senescence cells in the tumor microenvironment, which could be triggered by therapeutics or local stress conditions. Here, we provided a SASP Score in glioblastoma (GBM) with generating a SASP gene panel to identify the potential small molecular candidate targeting SASP in GBM. The effectiveness of this scoring method was firstly interrogated with our in-house GBM cohort and public datasets, including transcriptomic data from bulk and single cell GBM samples. Then, we validate this score with functional assays and transcriptomic profiling of Doxorubicin-induced senescence GBM cells. Multi-omics profiling with this score demonstrates that SASP facilitates IDH wild type glioma progression by modulating both the behaviors of malignant cells and tumor associated macrophages (TAMs), and discloses GDC-0879 as a feasible SASP inhibitor in GBM therapy. Its administration not only attenuates the tumorigenicity of GBM cells, but also sensitizes GBM to anti-PD1 in preclinical mouse models. Together, we provide a SASP evaluation approach in glioma, and use it to highlight the critical role of SASP in GBM progression and demonstrate GDC-0879 as a small molecule impairing GBM tumorigenicity and improving their response to anti-PD1.</p>
<figure class="fig xbox font-sm" id="Figa"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd59/12334699/29942d85534f/41419_2025_7915_Figa_HTML.jpg" loading="lazy" id="d33e272" height="434" width="633" alt="graphic file with name 41419_2025_7915_Figa_HTML.jpg"></p>
<div class="p text-right font-secondary"><a href="figure/Figa/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Created by Figdraw (<a href="http://www.figdraw.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.figdraw.com</a>).</p></figcaption></figure><section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> CNS cancer, Cancer immunotherapy</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par3">As a concomitant phenomenon during aging, cellular senescence is a crucial biological process for tissue regeneration and homeostasis maintenance, which is characterized by sustained cell cycle arrest and could be induced by diverse stress conditions such as low pH, hypoxia, and nutrient deficiency [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Senescence-associated secretory phenotype (SASP) is the paracrine signal released from senescence cells and constitutes a characteristic pro-inflammatory secretome. However, emerging evidences demonstrate that this fundamental physiological mechanism could be hijacked by cancer cells for their evolution and immune evasion [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. When senescence cells present proliferation arrest, the SASP signals released from them provide effective support for cancer progression by modulating the behaviors of residual malignant cells and non-tumor cell components in the tumor microenvironment (TME) to present cancer-promoting phenotypes [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>].</p>
<p id="Par4">To date, glioblastoma (GBM) remains an uncurable malignancy with only 6.8% 5-year overall survival [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. There is an urgent need for the development of an effective treatment strategies against GBM. Immunotherapy, represented by immune checkpoint blockade (ICB) has revolutionized cancer therapy in the past decade. However, only a few GBM exhibit effective responses to ICB [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>], in which the immunosuppressive TME is one of the leading causes limiting the efficiency of ICB in GBM. As a stress response, SASP has paradoxical impacts on the immune surveillance in TME. While it serves as a critical barrier for cancer progression through activating adaptive immunity, the paracrine signals and immune suppressive cytokines released by senescence malignant and non-cancerous cells contribute to the constitution of immune suppressive TME and act as a potential cancer resistance mechanism to immunotherapy [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. The understanding of multifaceted roles and flexible mechanisms of SASP in GBM may provide potential actionable cancer vulnerabilities for this frustrating disease. Modulating SASP in TME may improve GBM response to immunotherapy. However, the characterization of SASP in GBM progression and its role in regulating the response to immunotherapy remains to be elucidated. Additionally, given the heterogeneity of the cell population exhibiting SASP within the TME, it is essential to dissect the cell components and context-dependent mechanisms concomitant with SASP [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>], which remain quite limited.</p>
<p id="Par5">In the present study, to evaluate SASP activation status in glioma, we generated a SASP gene panel covering the features of senescence processes, including cell cycle arrest, nuclear change, DNA damage response, metabolic adaptation, and increased lysosomal activities, for constructing a SASP evaluation score (SASP Score) by ssGSEA method to stratify glioma patients. Functional assays and validation in multiple cancer senescence datasets demonstrated that the established SASP Score efficiently reflected the status of SASP activation. The application of this evaluation system implicated the involvement of SASP in the dysregulated immune responses and extensive infiltration of tumor-associated macrophages (TAMs) in GBM TME. Screening of small molecular inhibitors based on the SASP Score identified GDC-0879 as a potential antagonist of SASP in glioma, which implication significantly reduced GBM growth and improved their response to PD1 blockade in preclinical mouse models.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods and materials</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Ethics and human specimen collection</h3>
<p id="Par6">This study was approved by the Ethics Committee of Hospital of China Medical University (CMU). The animal experiment protocol was approved and performed under the supervision of the Institutional Animal Care and Use Committee in CMU.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Dataset availability</h3>
<p id="Par7">In-house CMU cohort incorporates bulk RNA-seq data of 30 cases of grade IV glioma samples, which includes 26 cases of IDH wildtype (wt) and 4 cases of IDH mutant (mut) samples, which is under accession code HRA006353 of the Genome Sequence Archive in National Genomics Data Center, China National Center for Bioinformation/Beijing Institute of Genomics, Chinese Academy of Sciences (<a href="https://bigd.big.ac.cn/gsa-human/browse/HRA006353" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://bigd.big.ac.cn/gsa-human/browse/HRA006353</a>). Glioma RNA-seq data of The Cancer Genome Atlas (TCGA) were obtained from GlioVis data portal (<a href="http://recur.bioinfo.cnio.es/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://recur.bioinfo.cnio.es/</a>), which consists of 428 glioma samples (Grade II 133 cases, grade III 145 cases, and GBM 150 cases) and includes 197 cases of IDH wt and 231 cases of IDH mut glioma samples [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Moreover, the RNA-seq data of 921 glioma samples with grade and IDH status information were downloaded from Chinese Glioma Genome Atlas (CGGA) website (<a href="http://www.cgga.org.cn" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.cgga.org.cn</a>), consisting of 312 glioma samples from CGGA325 dataset (Grade II 97 cases, grade III 74 cases, and GBM 137 cases, and 4 cases with not applicable grade information, which includes 145 cases of IDH wt and 167 cases of IDH mut samples) and 609 samples from CGGA693 dataset (Grade II 158 cases, grade III 224 cases, and GBM 227 cases, which includes 276 cases of IDH wt and 333 cases of IDH mut glioma samples). Gravendeel dataset was extracted from UCSC (<a href="https://xenabrowser.net/datapages/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://xenabrowser.net/datapages/</a>), including 226 glioma samples with grade information (Grade I 5 cases, grade II 22 cases, grade III 66 cases, GBM 128 cases, and 5 cases of samples with not applicable grade information, which includes 143 cases of IDH wt samples and 83 cases of IDH mut glioma samples). Bulk RNA-seq datasets (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271928" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE271928</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266210" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE266210</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274090" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE274090</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121422" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE121422</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE158743" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE158743</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208048" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE208048</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE212085" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE212085</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130727" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE130727</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE240377" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE240377</a>, and <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78220" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE78220</a>) were also obtained from Gene Expression Omnibus (GEO) database (<a href="https://www.ncbi.nlm.nih.gov/gds" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/gds</a>). <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271928" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE271928</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266210" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE266210</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274090" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE274090</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121422" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE121422</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE158743" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE158743</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208048" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE208048</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE212085" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE212085</a>, and <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130727" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE130727</a> were employed for the validation of SASP Score. <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78220" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE78220</a> was applied for the immunotherapy response and survival analysis. Van-Allen dataset was derived from the study “Genomic correlates of response to CTLA-4 blockade in metastatic melanoma” [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. IMvigor210 CoreBiologies data was downloaded with the R package provided by the following website (<a href="http://research-pub.gene.com/IMvigor210CoreBiologies/packageVersions/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://research-pub.gene.com/IMvigor210CoreBiologies/packageVersions/</a>). RNA-seq data for the SASP Score evaluation of GBM samples receiving TTF treatment was downloaded from the supplement information of Xu’s paper [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>].</p>
<p id="Par8">The analysis of single-cell RNA-seq (scRNA-seq) GBM datasets were derived from <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235676" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE235676</a> containing 149,048 cells from 24 GBM samples (5 newly diagnosed, 7 recurrent, and 12 receiving neoadjuvant combination therapy of pembrolizumab and anlotinib) [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>], <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131928" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE131928</a> containing 7930 single cell samples from 28 cases of GBM [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>], and <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84465" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE84465</a> containing 3589 single cell data from 4 GBM samples, respectively [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. All of these three scRNA-seq datasets were downloaded from GEO database (<a href="https://www.ncbi.nlm.nih.gov/gds" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/gds</a>). CGGA scRNA-seq data [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>] were extracted from CGGA website (<a href="http://www.cgga.org.cn/download.jsp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.cgga.org.cn/download.jsp</a>).</p></section><section id="Sec5"><h3 class="pmc_sec_title">Generation of gene panel for SASP evaluation in Glioma</h3>
<p id="Par9">The detailed information of SASP gene set (91 genes) generated in the present study and related references was listed in Table <a href="#MOESM1" class="usa-link">S1</a>. The SASP gene set was derived by performing an in-depth, rigorous literature search to predict the characteristics of SASPs (Table <a href="#MOESM1" class="usa-link">S1</a>), and predominantly consisted of SASP factors (<em>n</em> = 77), while including senescence markers (<em>n</em> = 14) covering different features of senescence (cell cycle arrest-associated factors, DNA damage response-associated factors, metabolic adaptation-associated factor, increased lysosomal content-associated factors, and nuclear change-associated factors) and more common in the central nervous system (CNS).</p></section><section id="Sec6"><h3 class="pmc_sec_title">Establishment of SASP score</h3>
<p id="Par10">The SASP Score for each sample was calculated using the R package “GSVA” with the ssGSEA method, based on a predefined gene panel (Table <a href="#MOESM1" class="usa-link">S1</a>) [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>].</p></section><section id="Sec7"><h3 class="pmc_sec_title">Cell culture</h3>
<p id="Par11">The primary patient-derived glioma stem-like cell (GSC0117) and adherent GBM cell (PGC62) used in this study were isolated from fresh surgical GBM specimens immediately after tumor resection [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. GSC0117 was cultured in Dulbecco’s modified Eagle’s medium (DMEM)/F12 medium (10565018, Gibco) containing 2% B27 supplement (175004044, Gibco), 20 ng/ml epidermal growth factor (EGF, AF-100-14, Peprotech), 20 ng/ml basic fibroblast growth factor (AF-100-18B, Peprotech), and 2.5 μg/ml heparin (H3149, Sigma). PGC62 and THP-1 (National Collection of Authenticated Cell Cultures, China, TCHu 57) were maintained in RPMI-1640 medium (RPMI) with 10% fetal bovine serum (FBS) (Gibco) and 1% penicillin/ streptomycin (Gibco). GL261 cells were maintained in DMEM (10566024, Gibco) supplemented with 10% FBS and 1% penicillin/ streptomycin.</p>
<p id="Par12">Mouse bone marrow-derived macrophages (BMDMs) were derived from C57BL/6 mice [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Briefly, after the mice were euthanized, the femur and tibia were removed and then bone marrow was flushed out with RPMI-1640 medium. The suspension was passed through a 70 μm stainless steel mesh and erythrocytes were lysed with red blood cell lysis buffer. Then, cells were collected by centrifugation and cultured in RPMI-1640 culture medium supplemented with 10% FBS and pre-charged with 20 ng/ml macrophage colony stimulating factor (416-ML, R&amp;D) for 2–3 days to induce mouse BMDMs. Mouse GBM cells (mGSCs) were isolated from spontaneous GBM tissues established by Sleeping Beauty (SB) transposon technique as previously described [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>] and cultured in stem cell medium (Neurobasal-A medium with the addition of B27, 10 ng/ml EGF, and 10 ng/ml FGF) at 37 °C in 5% CO<sub>2</sub>.</p></section><section id="Sec8"><h3 class="pmc_sec_title">RT-qPCR</h3>
<p id="Par13">After sample collection, total RNA was isolated with TRIzol™ Reagent [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>], and then was reversely transcribed into cDNA with PrimeScript™ RT Master Mix (Takara). qPCR was performed with TB Green® Premix Ex Taq™ II (RR820A, TaKaRa). The mRNA expression of target genes was calculated by 2<sup>−ΔΔCt</sup> method [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>] and normalized to 18S mRNA expression. The sequences of RT-qPCR primers were listed in Table <a href="#MOESM1" class="usa-link">S2</a>.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Bulk RNA-sequencing (Bulk-seq)</h3>
<p id="Par14">The total amount and integrity of RNA were assessed by the RNA Nano 6000 Assay Kit from the Bioanalyzer 2100 System (Agilent Technologies). Library fragments were purified using an AMPure XP system (Beckman Coulter). The insert size of the libraries was detected using an Agilent Bioanalyzer 2100. When the libraries were qualified, the different libraries were sequenced by Illumina NovaSeq 6000. All procedures were performed according to the manufacturer’s instructions. The differentially expressed genes (DEGs) was acquired using the ‘DEseq2’ R package (|log 2 FC| &gt; 1 and <em>P</em>.adj &lt; 0.05).</p></section><section id="Sec10"><h3 class="pmc_sec_title">Small molecule screening</h3>
<p id="Par15">Small molecule screening was performed following the described experimental procedures [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Briefly, to recognize specific gene-drug interactions of glioma cells, the data of 30 glioma cell lines were retrieved from the web portal of Cancer Cell Line Encyclopedia (CCLE) project (<a href="https://portals.broadinstitute.org/ccle" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://portals.broadinstitute.org/ccle</a>). After measuring the expression levels of SASP genes [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>], SASP Scores of each glioma cell line were calculated with the ssGSEA method. Then, the small molecular screening data (drug sensitivity profiles and glioma cell lines) were obtained from the Cancer Therapeutics Response Portal (CTRP project) [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. Area Under Curve (AUC) was employed to represent drug response, and a large or small AUC value was defined as resistant or sensitive, respectively. Spearman correlation analysis between SASP Score and AUC values of drug response was performed, and drug candidates with significant negative correlation (representing the sensitivity of drugs to SASP) were ranked. Finally, drugs with lower negative correlation values were supposed as potential SASP inhibitors of glioma cells.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Senescence induction and senescence-associated β-galactosidase staining</h3>
<p id="Par16">Senescence of indicated cell samples was induced by Doxorubicin treatment (200 nM) for 48 h [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Then, senescence cell samples were collected at the 5th day after senescence induction and applied for the following experiments as indicated. The senescence induction of cell samples was confirmed by senescence-associated β-galactosidase staining experiments, which was performed with a senescence-associated β-galactosidase staining kit (Beyotime Institute of Biotechnology) following the manufacturer’s protocol.</p></section><section id="Sec12"><h3 class="pmc_sec_title">Cell proliferation assays</h3>
<p id="Par17">After cell dissociation, single cell suspension of indicated cell samples (5 × 10<sup>3</sup> cells in 200 μl medium per well) were seeded into 96-well plates. After the indicated treatment, cell growth was measured according to the manufacturer’s instructions at indicated time points by adding 20 μl of MTS solution (G3581, Promega) to the wells and followed by 3 h incubation at 37 °C. The optical densities (OD) of each well were measured with a VICTOR Nivo Multi-Mode microplate reader at an absorbance of 490 nm.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Co-culture experiments</h3>
<p id="Par18">The co-culturing system was established using six well transwell inserts with 0.4 µm pore size (3450, Corning). The senescence cells were obtained by doxorubicin induction as mentioned above. For co-culture experiments, senescence induced or control cells were seeding into the transwell inserts and received GDC-0879 10 µM or DMSO treatment for 48 h. Then, the inserts containing 2 × 10<sup>5</sup> control or senescence induced cells were transferred into the wells of 6-well plate, which was pre-seeded with 2 × 10<sup>5</sup> untreated GBM cells. Then, after 48 h co-culture, GBM cells in the lower chambers were collected for migration, invasion, and proliferation assays.</p>
<p id="Par19">For co-culture experiments of macrophages and untreated GBM cells, 5 nM PMA was firstly added into transwell inserts containing 2 × 10<sup>5</sup> THP-1 cells to acquire macrophages.</p></section><section id="Sec14"><h3 class="pmc_sec_title">In vitro cell migration and invasion assays</h3>
<p id="Par20">Transwell chambers with a pore size of 8 μm (Corning, 3422) were used for cell migration and invasion assay in vitro [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. GBM cells after co-cultured with indicated GBM cells or macrophages for 48 h were resuspended in culture medium containing 0.2% FBS. Then, 200 µl cell suspension containing 1 × 10<sup>5</sup> cells (for migration assays) or 2 × 10<sup>5</sup> cells (for invasion assays) was seeded into the upper chambers of transwell inserts. Then, 600 µl of culture medium containing 20% FBS (for migration assays) or conditioned medium (CM) from indicated cell samples (for invasion assays) was added into the lower chamber. After 24 h co-culture, the chamber membranes were fixed with methanol and stained with 0.1% crystal violet solution. Cells on the upper side of the membrane were removed with a cotton swab, and cells migrating or invading to the lower side of the membrane were observed and photographed with an upright microscope.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Immunohistochemical (IHC) staining</h3>
<p id="Par21">IHC staining was performed according to the following procedures. After antigen retrieval and endogenous peroxidase blocking, the slides were treated with 3% bovine serum albumin, and then incubated with the corresponding primary antibody at 4 °C overnight, followed by secondary antibody treatment and DAB visualization. Protein expressions were quantified by German Immunohistochemical Score [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>].</p></section><section id="Sec16"><h3 class="pmc_sec_title">Flow cytometry (FACS)</h3>
<p id="Par22">The percentage of apoptotic cells in cell samples treated with GDC-0879 or Doxorubicin were detected by FACS with FITC Annexin V Apoptosis Detection Kit (BD Pharmingen), according to the manufacturer’s guidance. FACS analysis of orthotopic GBM tissues was performed following the protocol described previously [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. FlowJo software was applied for the analysis of FACS data.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Immunoblotting</h3>
<p id="Par23">Cell samples were collected and lysed with RIPA buffer containing PMSF (10:1) to extract protein. After protein quantification, each sample with equal micrograms of protein was loaded into a lane and followed by electrophoresis. Subsequently, the protein was electrotransferred to a 0.45 μm polyvinylidene difluoride membrane, which was blocked with 5% skimmed milk and incubated with the primary antibody solution at 4 °C overnight. Then, secondary antibodies were added to incubate the membranes at room temperature for 1 h. Protein bands were visualized with a chemiluminescence ECL reagent. All immunoblot results were independently repeated for at least three times and the antibodies are listed in Table <a href="#MOESM1" class="usa-link">S4</a>.</p></section><section id="Sec18"><h3 class="pmc_sec_title">Immunofluorescence staining</h3>
<p id="Par24">Tyrosine Signal Amplification (TSA) technology was employed for simultaneous labelling of multiple proteins on the same sample section (human GBM or mouse GBM samples), which enables quantitative immunofluorescence analysis of indicated proteins. Briefly, after gradient hydration of the sections, antigen repair and H<sub>2</sub>O<sub>2</sub> blocking were performed. The sections were further incubated with 3% BSA, and after gently shaking off the blocking solution, the primary antibody solution was added to the sections (The information of the antibodies are shown in Table <a href="#MOESM1" class="usa-link">S4</a>). After overnight incubation, the corresponding kind of HRP-labelled secondary antibody was added and washed three times with PBS. Then, the corresponding TSA was added and incubated for 10 min. After being washed with PBS three times, the sections were heated in a microwave oven to remove the primary and secondary antibodies that had been bound to the tissue. Then, the addition of the corresponding primary antibody-secondary antibody-TSA-microwave heating was repeated to complete the indicated TSA staining. Finally, the slides were washed, re-stained with DAPI, and blocked to obtain images. Immunofluorescence images were acquired by Pannoramic MIDI (3DHISTECH) and CaseViewer.</p>
<p id="Par25">For the analysis of immunofluorescence images with TSA labelling [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>], the percentages of senescence malignant cells (P21<sup>+</sup>/γ-H2AX<sup>+</sup>/Lamin B1<sup>−</sup>/GFAP<sup>+</sup>), senescence macrophages (P21<sup>+</sup>/γ-H2AX<sup>+</sup>/Lamin B1<sup>−</sup>/IBA1<sup>+</sup>), or senescence M2 macrophages (P21<sup>+</sup>/γ-H2AX<sup>+</sup>/Lamin B1<sup>−</sup>/CD163<sup>+</sup>) cells were separately calculated by counting the number of GFAP<sup>+</sup>, IBA1<sup>+</sup> or CD163<sup>+</sup> cells that also co-stained with P21<sup>+</sup>/γ-H2AX<sup>+</sup>/Lamin B1<sup>−</sup> per visual field (human GBM samples, ×80). The mouse GBM samples are also analyzed using the same methods as human GBM samples (per visual field, ×125). For apoptotic cells, the percentages of apoptotic malignant cells (Cleaved casepase3<sup>+</sup>/GFAP<sup>+</sup>), and apoptotic macrophages (Cleaved casepase3<sup>+</sup>/ IBA1<sup>+</sup>) were individually estimated by counting the number of GFAP<sup>+</sup> and IBA1<sup>+</sup> cells that also co-stained with Cleaved casepase3<sup>+</sup> per visual field (×125). The total number of cells in three non-overlapping high-power fields was counted from randomly selected human or mouse GBM samples. Three replicates were performed for each group.</p></section><section id="Sec19"><h3 class="pmc_sec_title">Mouse intracranial xenograft model</h3>
<p id="Par26">To establish mouse orthotopic GBM xenograft model, C57BL/6 mouse was stereotactically injected with 5 × 10<sup>5</sup> GL261 cells or 5 × 10<sup>4</sup> mGSCs obtained from SB transposon-derived mouse GBM sample with primary culture technique into the right cerebral cortex at a depth of 3.5 mm [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Then, the mice were randomly assigned into 4 groups: Control: received a single oral dose of 0.5% methylcellulose/0.2% Tween 80 (MCT) and IgG2b isotype control; GDC-0879: GDC-0879 (100 μg/g body weight) in MCT was orally administered by gavage daily from 7th to 21st day; Anti-PD1: Anti-PD1 antibody (10 μg/g body weight) was injected intraperitoneally on the 5th, 8th, and 11th day; Combined treatment: treated with GDC-0879 and Anti-PD1). Intracranial tumor formation was confirmed by bioluminescence assay on the 7th day after the implantation of GL-261 and mouse GBM cells. Anti-PD1 antibody (10 μg/g body weight) was injected intraperitoneally on the 5th, 8th, and 11th day [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. GDC-0879 (100 μg/g body weight) was orally administered by gavage daily from 7th to 21st day. The mice were executed on day 21 for FACS and IHC analysis, or observed to present neurological symptoms and then sacrificed for survival analysis.</p></section></section><section id="Sec20"><h2 class="pmc_sec_title">Bioinformatic analysis</h2>
<section id="Sec21"><h3 class="pmc_sec_title">Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA)</h3>
<p id="Par27">GO biological processes (BP) and KEGG analysis were performed based on the genes positively related to SASP Score (<em>R</em> ≥ 0.6, Spearman correlation analysis) with IDH wt glioma samples from indicated datasets by DAVID (<a href="https://david.ncifcrf.gov/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://david.ncifcrf.gov/</a>) [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. GSEA (<a href="http://www.broadinstitute.org/gsea/index.jsp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.broadinstitute.org/gsea/index.jsp</a>) was conducted to analyze the enrichment of indicated phenotypes between high and low SASP Score groups using the median SASP Score as a threshold. Normalized enrichment score (NES) and false discovery rate were used to determine the statistical significance.</p></section><section id="Sec22"><h3 class="pmc_sec_title">Tracking tumor immunophenotype (TIP) analysis</h3>
<p id="Par28">TIP analysis was performed with the website tool (<a href="http://biocc.hrbmu.edu.cn/TIP/index.jsp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://biocc.hrbmu.edu.cn/TIP/index.jsp</a>), according to the protocol provided [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. TCGA IDH wt glioma transcriptome expression profile was used as an input file for the online analysis. The score of different immune cells recruited in Step 4 were summed to derive a total score for “Step 4: Trafficking of immune cells to tumor”.</p></section><section id="Sec23"><h3 class="pmc_sec_title">Immune cell component estimation with Xcell and Cibersort</h3>
<p id="Par29">R package “Estimate” was used to evaluate tumor purity in the TME and calculate the Immune, Stromal, and Estimate scores in TCGA IDH wt glioma dataset [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. The abundance of immune cells in IDH wt glioma samples of TCGA/CGGA325/CGGA693/Gravendeel datasets was quantified by Xcell (<a href="https://xcell.ucsf.edu/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://xcell.ucsf.edu/</a>) [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>], Microenvironment cell populations (MCP)-counter [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>], and ssGSEA [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>].</p></section><section id="Sec24"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par30">All statistical analyses were performed using Microsoft Excel 2019 or Prism 8 unless indicated otherwise. The data were expressed as Mean ± S.D., and two-tailed <em>t</em>-test or one-way ANOVA (Turkey’s post-test) was employed to determine the differences between two or among more groups, respectively. <em>P</em> &lt; 0.05 was considered to be statistically significant. Univariate and Multivariate Cox regression analyses were performed by R package “Survival”. Hazard Ratio (HR) calculated &gt; 1 was considered as risky factor, while HR &lt; 1 was regarded as protective factor. Kaplan–Meier survival curves and the log-rank test were employed to evaluate the prognostic significance. R package “pheatmap” was used for making heat maps by R (version 4.2.1). R package “GSVA” (<a href="http://www.bioconductor.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.bioconductor.org</a>) was used to assess the underlying pathway activity variation according to the gene-sets of defined signaling pathways. R package “Maftools” was employed to illustrate significant mutation information of SASP-related genes.</p></section></section><section id="Sec25"><h2 class="pmc_sec_title">Result</h2>
<section id="Sec26"><h3 class="pmc_sec_title">Establishing SASP Score to evaluate SASP activation in glioma</h3>
<p id="Par31">Considering the potential versatile roles of cellular senescence and SASP in cancer biology, we firstly sought to summarize an optimized SASP panel for the comparative evaluation of SASP status in glioma. Given the context-dependent nature of SASP and the defects of single senescence marker, we generated a characterized SASP gene set containing 91 genes through literature inquiry, including recent SenNet paper (Table <a href="#MOESM1" class="usa-link">S1</a>). Our SASP gene panel incorporated 77 genes encoding classical SASP factors (Table <a href="#MOESM1" class="usa-link">S1</a>; including 20 chemokines, 21 growth factors and regulators, 18 proteases and regulators, 9 soluble or shed receptors or ligands, 7 interleukins, and 2 other inflammatory factors). Moreover, it has been previously reported that, in the absence of cell-cycle arrest (non-senescence state), brain cells also secrete inflammatory molecules that overlap with SASP factors [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Thus, to circumvent the possibility of misidentifying the SASP gene set as inflammatory components normally detected in cells rather than a critical SASP, we also brought 14 well-recognized senescence markers into our gene set. These markers not only cover the classical senescence markers of CNS, but also include the molecules reflecting the hallmarks of cancer senescence including cell cycle arrest (CDKN1A, CDKN2A, CDKN2B, CDKN2D, MTOR, PCNA, SATB1, and TP53), DNA damage response (MACROH2A1), anti-apoptotic pathway activation (BCL2), increased lysosomal content (GLB1, LGALS3, and LGALS3BP), and nuclear change (LMNB1) (Table <a href="#MOESM1" class="usa-link">S1</a>). Then, we employed ssGSEA method to develop an SASP Score to evaluate the status of SASP activation in glioma samples (Fig. <a href="#Fig1" class="usa-link">1A</a> and Table <a href="#MOESM1" class="usa-link">S3</a>) [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>].</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. Establishment of SASP Score reflects SASP activation in cancer.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334699_41419_2025_7915_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd59/12334699/d466932e07a2/41419_2025_7915_Fig1_HTML.jpg" loading="lazy" id="d33e791" height="999" width="730" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> The schematic graph showing the establishing procedures of SASP Score with ssGSEA method and the SASP gene panel summarized from published reports according to senescence hallmarks listed in Table <a href="#MOESM1" class="usa-link">S1</a>. <strong>B</strong>, <strong>C</strong> Representative SA-β-gal staining images of indicated GBM cells (<strong>B</strong>: PGC62 and <strong>C</strong>: GSC0117) with control (DMSO) or Doxorubicin (200 nM) (<em>n</em> = 3, <em>t</em>-test). Scale bar, 50 μm. <strong>D</strong>, <strong>E</strong> The analysis of RNA-seq data obtained from PGC62 (<strong>D</strong>) and GSC0117 (<strong>E</strong>) samples with control (DMSO) or Doxorubicin (200 nM) treatment indicating the elevation of SASP Score accompanied with senescence induction by Doxorubicin treatment in these cells (<em>n</em> = 3). <strong>F</strong>, <strong>H</strong> The analysis of RNA-seq data obtained from PGC62 (<strong>F</strong>) and GSC0117 (<strong>H</strong>) samples with control (DMSO) or Doxorubicin (200 nM) treatment showing the elevation of SASP Score reflects the upregulation of SASP associated genes. <strong>G</strong>, <strong>I</strong> The analysis of differentially expressed genes (DEGs) according to RNA-seq data obtained from PGC62 (<strong>G</strong>) and GSC0117 (<strong>I</strong>) samples with control (DMSO) or Doxorubicin (200 nM) treatment (with DESeq2). <strong>J</strong>, <strong>K</strong> Gene Ontology (GO) biological process analysis with RNA-seq data obtained from PGC62 (<strong>J</strong>) and GSC0117 (<strong>K</strong>) samples with control (DMSO) or Doxorubicin (200 nM) treatment. (**** <em>P</em> &lt; 0.0001).</p></figcaption></figure><p id="Par32">Next, considering the heterogeneity of senescence in different tissues, we collected 8 senescence GEO datasets and compared our SASP Score with 4 other senescence signatures, including SenMayo [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>–<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. These 8 senescence-related GEO datasets encompass 9 distinct induction strategies for cellular or tissue senescence, including both tumor and non-tumor models: <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271928" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE271928</a>, radiation-induced senescence in GBM cell lines A172 and LN229; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266210" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE266210</a>, p16_high (senescence) and p16_low (non-senescence) in GBM tissues; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274090" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE274090</a>, radiation-induced senescence in U251 GBM cells; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121422" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE121422</a>, radiation-induced senescence in LN229 GBM cells; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE158743" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE158743</a>, radiation-induced senescence in U2OS human osteosarcoma cells; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208048" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE208048</a>, palbociclib-induced senescence in SK-MEL-103 melanoma cells; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE212085" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE212085</a>, doxorubicin-induced senescence in IMR90 fibroblast cells; <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130727" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE130727</a>, doxorubicin-induced senescence in WI-38 fibroblast cells. We established the individual senescence scores for our SASP panel and the other four signatures by ssGSEA in the senescence datasets, respectively, and compared them with the non-senescence control models. Our analysis revealed that five established senescence signatures exhibited marked upregulation in the majority of senescence models. However, with the exception of our SASP Score, none of the existing signatures (including SenMayo) demonstrated consistent upregulation across all nine senescence induction paradigms (Fig. <a href="#MOESM1" class="usa-link">S1A</a>). This may be attributable to the heterogeneity of senescence phenotypes and SASP composition across tissues. These findings highlight the superiority of our SASP Score in achieving better efficacy in senescence characterization among different senescence models. Collectively, our data indicate that SASP scoring with the current SASP gene panel and ssGSEA method serves as a suitable approach to evaluate the status of SASP activation in glioma.</p></section><section id="Sec27"><h3 class="pmc_sec_title">Functional experiments in GBM cells reveal that the SASP Score efficiently represents the status of SASP activation</h3>
<p id="Par33">Next, we also sought to test whether the elevation of this SASP score effectively represented SASP activation. We firstly validated our SASP scoring method in a dataset (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE240377" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE240377</a>) which includes the data obtained from four senescence-induced GBM cell lines by TMZ or radiotherapy [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. The result demonstrated that SASP Score was significantly up-regulated in TMZ/radiotherapy-induced senescence GBM cells (Fig. <a href="#MOESM1" class="usa-link">S2A</a>). This supports the representative of our SASP score in the evaluation of glioma senescence. Then, we acquired senescence GBM cells with the well-recognized Doxorubicin-induced senescence method [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Senescence in two primary GBM cell lines (primary adherent GBM cell PGC62 and GBM stem-like cell GSC0117, Table <a href="#MOESM1" class="usa-link">S4</a>) was induced by 200 nM Doxorubicin treatment and confirmed by the expression validation of two well-recognized senescence markers, SA-β-gal and P21. We observed enhanced intensities of SA-β-gal staining and elevated mRNA expression of P21 after Doxorubicin treatment in these cells (Figs. <a href="#Fig1" class="usa-link">1B, C</a> and <a href="#MOESM1" class="usa-link">S2B, C</a>). Moreover, qPCR analysis disclosed that mRNA expression of SASP factors in these cells (IL6, IL1α, IL1β, TNFα, CXCL10, MMP3, CXCL10, and CCL2) were increased with Doxorubicin treatment (Fig. <a href="#MOESM1" class="usa-link">S2B, C</a>). These results support the successful senescence induction in these two GBM cell lines. Thus, we employed these cell samples to evaluate the representative of our SASP scoring method for SASP activation. Indeed, ssGSEA analysis of RNA-seq data obtained from these samples showed a significant elevation of the SASP Score in Doxorubicin-treated cells compared to control samples (Fig. <a href="#Fig1" class="usa-link">1D, E</a>). Subsequent heatmap analysis revealed that the upregulation of our SASP Score efficiently reflected the elevation of SASP-related gene expression in these two GBM cell lines (PGC62, Fig. <a href="#Fig1" class="usa-link">1F</a>; GSC0117, Fig. <a href="#Fig1" class="usa-link">1H</a>). The enrichment analysis of DEGs between Doxorubicin-treated and control samples demonstrated that the DEGs were mainly enriched in signal transduction and oncogenic pathways like MAPK cascade (DEGs: Fig. <a href="#Fig1" class="usa-link">1G, I</a> and Table <a href="#MOESM1" class="usa-link">S5</a>; GO: Fig. <a href="#Fig1" class="usa-link">1J, K</a>; KEGG: Fig. <a href="#MOESM1" class="usa-link">S2D, E</a>).</p>
<p id="Par34">Given that SASP includes a range of pro-inflammatory factors [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>], we sought to distinguish whether the elevation of our SASP Score reflects the activation of SASP rather than inflammatory state in cells. We established 4 inflammatory state scores from 4 inflammatory state-associated gene sets obtained from the Molecular Signatures Database [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>] (Table <a href="#MOESM1" class="usa-link">S6</a>) by the ssGSEA method. According to analyzing RNA-seq data of Doxorubicin-induced senescence and control PGC62 and GSC0117 samples, the SASP Score was significantly increased in senescent induced samples, whereas the inflammatory state scores didn’t show a consistent elevation in senescence induced samples (Fig. <a href="#MOESM1" class="usa-link">S2F, G</a>). Collectively, these data demonstrated the effectiveness of current SASP panel in representing SASP activation in GBM cells.</p></section><section id="Sec28"><h3 class="pmc_sec_title">SASP activation is a feature for the malignant progression of IDH wt glioma</h3>
<p id="Par35">Due to the paradoxical roles of SASP in cancer, we sought to delineate SASP activation status in glioma and examine the inter-relationship between SASP activation and malignant progression of glioma with our SASP Score. Since IDH status is the most prominent molecular characteristic in glioma, we firstly employed the SASP Score to analyze SASP activation in glioma samples with different IDH status from five glioma bulk-tumor transcriptomic cohorts, including our in-house GBM RNA-seq dataset (Table <a href="#MOESM1" class="usa-link">S7</a>). IDH wt glioma consistently exhibited a significantly higher SASP Score in comparison with IDH mut glioma across all five glioma cohorts, indicating a more active SASP in IDH wt glioma compared to IDH mut glioma. Therefore, we chose IDH wt glioma for further investigation (Figs. <a href="#Fig2" class="usa-link">2A, B</a> and <a href="#MOESM1" class="usa-link">S3A</a>). Besides, consistently with the analysis shown in Fig. <a href="#Fig1" class="usa-link">1F and H</a>, increased SASP Score efficiently reflected the mRNA upregulation of SASP genes (Figs. <a href="#Fig2" class="usa-link">2C, D</a>, and <a href="#MOESM1" class="usa-link">S3B</a>), which indicated that the SASP Score could effectively represent the SASP-related gene expression in IDH wt glioma and could be employed for the evaluation of SASP activation. Through dividing the samples into high and low SASP Score groups using the median SASP Score as a threshold, we observed more EGFR (26.67%), PTEN (27.14%), and NF1 (10%) mutations in the high SASP Score group than low SASP Score group (EGFR (1.90%), PTEN (0.95%), NF1 (4.76%)) of glioma (Fig. <a href="#Fig2" class="usa-link">2E</a>). We also observed a few BRAF mutations (1.43%) in the high SASP Score group of glioma (Fig. <a href="#Fig2" class="usa-link">2E</a>). In contrast, ATRX mutation (43.81%), which was considered as a molecular signature of low-grade glioma (LGG), was more likely to occur in the low SASP Score group than high SASP Score group (14.76%) (Fig. <a href="#Fig2" class="usa-link">2E</a>). Additionally, EGFR amplification (44.60%) and PTEN (8.92%) deletion were more common in the high SASP Score group than low SASP Score group (EGFR 1.89%, PTEN 4.25%) (Fig. <a href="#Fig2" class="usa-link">2F</a>) [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Interestingly, there were more samples with TP53 mutation in low SASP Score group (54.76%) than high SASP Score group (34.29%) (Fig. <a href="#Fig2" class="usa-link">2E</a>), indicating a potential context-dependent role of p53 in regulating glioma senescence.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. SASP activation is a critical characteristic for the malignant progression of IDH wt glioma.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334699_41419_2025_7915_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd59/12334699/e60faaa51665/41419_2025_7915_Fig2_HTML.jpg" loading="lazy" id="d33e1084" height="996" width="711" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> The SASP Score analysis of IDH wt and mut glioma according to indicated datasets (<strong>A</strong>: CMU GBM, <em>n</em> = 30, Wildtype: <em>n</em> = 26; Mutation: <em>n</em> = 4; <strong>B</strong>: TCGA glioma, <em>n</em> = 428, Wildtype: <em>n</em> = 197; Mutation: <em>n</em> = 231; The samples with unknown IDH status weren’t included in the analysis). <strong>C</strong>, <strong>D</strong> The analysis of CMU and TCGA datasets showing that the elevation of SASP Score reflects the upregulation of SASP associated genes in IDH wt glioma (<strong>C</strong>: CMU IDH wt GBM, <em>n</em> = 26; <strong>D</strong>: TCGA IDH wt glioma, <em>n</em> = 197). <strong>E</strong>, <strong>F</strong> The characterization of SASP in glioma with established SASP Score based on the indicated key genomic and clinical features of glioma (<strong>E</strong> Somatic mutation: TCGA Glioma, <em>n</em> = 420, Not Applicable = 8; <strong>F</strong> Copy number variations (CNV): TCGA Glioma, <em>n</em> = 425, Not Applicable = 3). <strong>G</strong> Kaplan–Meier analyses revealing that high SASP Score indicates unfavorable prognosis in IDH wt glioma (TCGA IDH wt glioma <em>n</em> = 197: high <em>n</em> = 99, low <em>n</em> = 98). <strong>H</strong> The univariate (Left) and multivariate analyses (Right) indicating the elevation of SASP Score as an independent prognosis factor of IDH wt glioma (TCGA IDH wt glioma, <em>n</em> = 197). <strong>I</strong> The evaluation of SASP Score in indicated subtypes of GBM (TCGA GBM RNA-seq dataset, <em>n</em> = 141: proneural <em>n</em> = 36, classical <em>n</em> = 56, and mesenchymal <em>n</em> = 49; Wilcoxon rank sum test). <strong>J</strong> The SASP Score analysis in four GBM malignant cellular states, indicating the enrichment of SASP Score in AC-like and MES-like cellular states, which are significantly higher that other two malignant cellular states, OPC-like and NC-like (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131928" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE131928</a>, <em>n</em> = 6576; Left: Two-dimensional representation of cellular states. Each quadrant corresponds to one cellular state, the exact positions of malignant cells (dots) reflects their relative scores for the meta-modules; Right: The analysis of cell-state plots based on SASP Scores of single cell samples in each cell-state; NPC, <em>n</em> = 1986; OPC, <em>n</em> = 1047; AC, <em>n</em> = 1614; MES, <em>n</em> = 1929; Wilcoxon test). <strong>K</strong> The schematic graph showing the co-culture method of GBM cells with Doxorubicin (200 nM) treatment (Upper chamber) and untreated GBM cells (Lower chamber). <strong>L, M</strong> MTS assays of indicated GBM cell samples (<strong>L</strong> PGC62; <strong>M</strong> GSC0117; <em>n</em> = 3, one-way ANOVA). <strong>N, O</strong> Representative images (Left) and analysis (Right) of Transwell invasion assays of indicated GBM cell samples (<strong>N</strong> PGC62; <strong>O</strong> GSC0117; <em>n</em> <em>=</em> 3, <em>t</em>-test). Scale bar, 50 μm. (ns not significant, ** <em>P</em> &lt; 0.01, *** <em>P</em> &lt; 0.001, **** <em>P</em> &lt; 0.0001).</p></figcaption></figure><p id="Par36">Next, we examined whether elevated SASP Score indicates poor survival in IDH wt glioma. After the patient samples in the above four IDH wt glioma datasets (TCGA/CGGA325/CGGA693/Gravendeel datasets) were stratified into high and low SASP Score groups with the median value of SASP Score, survival analysis disclosed a consistent shorter patient survival of high SASP Score groups than low SASP Score group in IDH wt glioma (Figs. <a href="#Fig2" class="usa-link">2G</a> and <a href="#MOESM1" class="usa-link">S3C</a>). Then, to further distinguish tumor samples based on SASP activation status, we classified all tumor samples using ConsensusClusterPlus method [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>], which specified groups with common biological characteristics (Fig. <a href="#MOESM1" class="usa-link">S3D, E</a>). With the selection of <em>K</em> = 2 to classify IDH wt glioma samples (TCGA RNA-seq dataset, <em>n</em> = 197) into Cluster 1 and 2 (Fig. <a href="#MOESM1" class="usa-link">S3F</a>), principal component analysis (Fig. <a href="#MOESM1" class="usa-link">S3G</a>) and survival evaluation on these two clusters (Fig. <a href="#MOESM1" class="usa-link">S3H</a>) disclosed that Cluster 1 had a significantly better survival trend compared to Cluster 2, while exhibiting a lower SASP Score (Fig. <a href="#MOESM1" class="usa-link">S3I</a>). Additionally, both univariate and multivariate analyses revealed that the elevation of the SASP Score could serve as an independent poor survival predictor for IDH wt glioma, regardless of common clinical characteristics including gender, radiotherapy, and age (Figs. <a href="#Fig2" class="usa-link">2H</a> and <a href="#MOESM1" class="usa-link">S4A</a>). Moreover, the analysis between SASP Score and GBM subtypes in TCGA, CGGA325, CGGA693, and Gravendeel four cohorts revealed that the mesenchymal (MES) GBM, the most aggressive GBM subtype [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>], exhibited higher SASP Score compared to the Proneural (PN) and Classical (CL) subtypes (Figs. <a href="#Fig2" class="usa-link">2I</a> and <a href="#MOESM1" class="usa-link">S4B</a>). Moreover, we evaluated SASP activation status of GBM cells based on four malignant cellular states, which also disclosed an elevated SASP Score in MES-like and AC-like cellular states (Fig. <a href="#Fig2" class="usa-link">2J</a>). The analysis of genes positively associated with SASP Score elevation (Table <a href="#MOESM1" class="usa-link">S8</a>, <em>R</em> &gt; 0.6, Spearman analysis) through GO BP and KEGG analysis revealed significant enrichment of BP and pathways associated with tumorigenesis and tumor development in high SASP Score groups (Fig. <a href="#MOESM1" class="usa-link">S5A</a>). Lastly, to verify whether SASP strengthened the malignant behaviors of GBM cells like proliferation and invasion, we co-cultured Doxorubicin-induced senescence GBM cells with untreated GBM cells (Fig. <a href="#Fig2" class="usa-link">2K</a>). Indeed, senescence GBM cells enhanced the proliferation (Fig. <a href="#Fig2" class="usa-link">2L, M</a>) and invasion abilities of untreated GBM cells (Fig. <a href="#Fig2" class="usa-link">2N, O</a>), indicating intercellular bioactive mediators released from senescence cancer cells to strengthen the malignant behaviors of GBM cells without senescence induction. Collectively, these data obtained from the analysis based on present SASP Score support SASP activation as a prominent feature accompanying with the malignant progression of IDH wt glioma.</p></section><section id="Sec29"><h3 class="pmc_sec_title">Elevation of SASP Score indicates dysregulated immune responses and extensive infiltration of macrophages in IDH wt glioma</h3>
<p id="Par37">Considering that SASP contributes to the constitution of TME by impacting immune cell infiltration [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>], we sought to examine whether the SASP Score could be employed to evaluate dysregulated immune responses in IDH wt glioma. Enrichment analysis of genes with a positive correlation coefficient &gt; 0.6 with SASP Score elevation in IDH wt glioma disclosed a consistent enrichment in immune-related BP and KEGG pathways (Table <a href="#MOESM1" class="usa-link">S8</a>) (TCGA, CGGA325, CGGA693, and Gravendeel datasets; Fig. <a href="#MOESM1" class="usa-link">S6A, B</a>). Cancer hallmark analysis with GSEA suggested the enrichment of tumorigenesis-associated pathways and immune-related pathways in samples with SASP Score elevation, such as hallmark of angiogenesis, apoptosis and epithelial-mesenchymal transition, and inflammatory, interferon α, and interferon γ responses (Fig. <a href="#MOESM1" class="usa-link">S7A</a>). Additionally, in terms of immune infiltration and TME analysis, an increased SASP score showed a significant positive correlation with Immune, Stromal, and ESTIMATE scores, while exhibiting a negative correlation with tumor purity (Fig. <a href="#Fig3" class="usa-link">3A, B</a>). These results support the association of higher SASP Score with more complex TME constitution in IDH wt glioma [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>].</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. The elevation of SASP Score indicates deregulated immune responses and extensive infiltration of macrophages in GBM.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334699_41419_2025_7915_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd59/12334699/49e0bd0ed74b/41419_2025_7915_Fig3_HTML.jpg" loading="lazy" id="d33e1265" height="1000" width="735" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> The correlation analysis of SASP and indicated scores (Left, Immune Score; Middle left, Stromal Score; Middle right, ESTIMATE Score; Right, Purity Score) in CMU IDH wt GBM (<strong>A</strong>, <em>n</em> = 26) and TCGA IDH wt glioma samples (<strong>B</strong>, <em>n</em> = 197, Spearman correlation analysis). <strong>C</strong> GSEA analysis revealing a potential stronger negative regulation of immune responses in IDH wt glioma samples with high SASP Score than samples with low SASP Score (CMU IDH wt GBM <em>n</em> = 26: high <em>n</em> = 13; low <em>n</em> = 13; TCGA IDH wt glioma <em>n</em> = 197: high <em>n</em> = 99; low <em>n</em> = 98). <strong>D</strong> The correlation analysis of indicated non-malignant immunosuppressive cell populations and indicated immunosuppressive terms in IDH wt glioma (CMU IDH wt GBM <em>n</em> = 26; TCGA IDH wt glioma <em>n</em> = 197; Term 1: GOBP negative regulation of alpha beta T cell activation; Term 2: GOBP negative regulation of immune responses; Term 3: GOBP negative regulation of immune system process; Term 4: GOBP negative regulation of T cell differentiation; Term 5: GOBP negative regulation of T cell mediated immunity; Term 6: GOBP negative regulation of T cell proliferation; Spearman analysis). <strong>E</strong> GSEA analysis revealing a significant close correlation of SASP Score elevation and macrophage activation involved in immune response (CMU IDH wt GBM <em>n</em> = 26; TCGA IDH wt glioma <em>n</em> = 197). <strong>F</strong> The correlation analysis of SASP Score and monocytic lineage based on MCP counter method, as well as that of SASP Score and macrophages based on ssGSEA method, according to indicated glioma datasets (CMU IDH wt GBM <em>n</em> = 26; TCGA IDH wt glioma <em>n</em> = 197). (ns not significant, * <em>P</em> &lt; 0.05, ** <em>P</em> &lt; 0.01, *** <em>P</em> &lt; 0.001).</p></figcaption></figure><p id="Par38">Then, we employed TCGA IDH wt glioma dataset to analyze the anti-cancer immune status of IDH wt glioma by exploring the seven-step cancer immune cycle in TME [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. IDH wt glioma samples with high SASP Score exhibited enhanced activities in Step 1 (The release of cancer cell antigens), Step 2 (Presentation of tumor antigens), and Step 4 (Transport of immune cells to the tumor). IDH wt glioma samples with low SASP Score had increased activities in Step 3 (The initiation and activation of anti-cancer immunity) and Step 6 (Recognition of cancer cells by T cells) (Fig. <a href="#MOESM1" class="usa-link">S8A</a> and Table <a href="#MOESM1" class="usa-link">S9</a>). These results implied that although SASP activation contributes to the initiation and processing phases of the immune responses, the activation of critical immune responses and recognition of cancer cells by T cells at these phases are inhibited, and the enrichment of SASP Score is still detrimental to the effective anti-tumor immune response. Moreover, GSEA analysis of IDH wt glioma showed that antitumor immune function was suppressed in high SASP Score group (Figs. <a href="#Fig3" class="usa-link">3C</a> and <a href="#MOESM1" class="usa-link">S8B</a>, and Table <a href="#MOESM1" class="usa-link">S10</a>). Notably, IDH wt glioma samples with elevated SASP Score exhibits higher expression of immune checkpoint molecules, either co-stimulatory or co-suppressive, compared to samples with low SASP Score (Fig. <a href="#MOESM1" class="usa-link">S8C</a> and Table <a href="#MOESM1" class="usa-link">S11</a>). This may be explained by the “immune tidal model theory”. It has been described that co-stimulatory and co-suppressive immune checkpoints determine the direction and extent of specific immune responses [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. While co-stimulatory immune checkpoints promote immune responses, secondary co-inhibitory immune checkpoints act as effective negative feedback signals for co-stimulatory factors, and these two roles are highly diverse in monitoring and regulating immune responses, thus potentially contributing to the composition of the immunosuppressive TME. The correlation analysis of three immunosuppressive cell components (Macrophages, neutrophils, and Tregs) and immune suppression pathways in IDH wt glioma disclosed that macrophages were identified to be positively correlated with dampened antitumor immunity in IDH wt glioma (Figs. <a href="#Fig3" class="usa-link">3D</a> and <a href="#MOESM1" class="usa-link">S9A</a> and Table <a href="#MOESM1" class="usa-link">S12</a>). The Step 4 analysis of immune cell proportions infiltrating in cancer revealed that SASP activation was positively correlated with the infiltration of macrophages and T cell helper cells, but negatively correlated with the recruitment of CD4 + T cells and CD8 + T cells in IDH wt glioma (Fig. <a href="#MOESM1" class="usa-link">S8A</a> and Table <a href="#MOESM1" class="usa-link">S13</a>). GSEA analysis also supported that SASP was closely related to the activation of macrophages in IDH wt glioma (Figs. <a href="#Fig3" class="usa-link">3E</a> and <a href="#MOESM1" class="usa-link">S9B</a>). The analysis with Xcell algorithm indicated more M2 TAMs infiltration in high SASP scoring samples of IDH wt glioma (Fig. <a href="#MOESM1" class="usa-link">S9C</a>) [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Besides, the analysis with MCP counter and ssGSEA algorithm indicated the positive correlation between SASP Score elevation and the infiltration of monocytic lineage cells, especially macrophages, in IDH wt glioma (Figs. <a href="#Fig3" class="usa-link">3F</a> and <a href="#MOESM1" class="usa-link">S9D</a>) [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Collectively, these results supported a positive association of SASP Score elevation to dysregulated immune responses and TAMs infiltration in IDH wt glioma, suggesting an unfavorable role of SASP in anti-tumor immunity within TME of IDH wt glioma.</p></section><section id="Sec30"><h3 class="pmc_sec_title">Malignant cells and TAMs are the two most abundant cell populations exhibiting SASP in GBM TME</h3>
<p id="Par39">To further investigate the senescent cell populations in GBM, we performed multiple immunofluorescence (IF) staining analysis on clinical GBM samples. With the employment of markers for senescence cell (P21, γ-H2AX, and Lamin B1), GBM cells (GFAP), Macrophages (IBA1), and M2 macrophages (CD163), we observed that there were significantly more senescent TAMs (detected by P21, γ-H2AX and IBA1 positive, and Lamin B1 negative) than senescent GBM cells (P21, γ-H2AX, and GFAP positive, and Lamin B1 negative) in GBM tumors, and that there was a higher infiltration of M2 TAMs (CD163 positive) in GBM (Fig. <a href="#Fig4" class="usa-link">4A</a>). We next sought to delineate the major cell components presenting SASP in GBM TME. We firstly employed a scRNA-seq GBM cohort (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235676" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE235676</a>) to examine the cell components with elevated SASP Score in GBM TME. This analysis revealed that myeloid cells, particularly macrophages, were the most abundant populations with heightened SASP scores in the TME (Fig. <a href="#Fig4" class="usa-link">4B</a>). Quantitative analysis further disclosed that TAMs were the cell component with the highest SASP Score in GBM (Fig. <a href="#Fig4" class="usa-link">4B</a>). The validation in another three scRNA-seq GBM datasets (CGGA, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84465" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE84465</a>, and <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131928" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE131928</a>) demonstrated malignant cells and TAMs, as well as T cells, were the cell populations with elevated SASP Score (Fig. <a href="#Fig4" class="usa-link">4C–E</a>). Interestingly, the median SASP Score of malignant cells is significantly lower than that of TAMs (Fig. <a href="#Fig4" class="usa-link">4C–E</a>). This result may be attributed to the heterogenicity of GBM cells. Together, these findings suggested that TAMs and malignant cells were the two most abundant cell populations exhibiting SASP in GBM.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. Malignant cells and TAMs present elevated SASP Score in GBM TME.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334699_41419_2025_7915_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd59/12334699/0dc446afff74/41419_2025_7915_Fig4_HTML.jpg" loading="lazy" id="d33e1398" height="999" width="726" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Representative immunofluorescence images of clinical GBM samples. Tumor staining shows the distributions of DAPI (Dark blue), P21 (Red), γ-H2AX (Orange), Lamin B1 (Yellow), GFAP (Green), IBA1 (Cyan), and CD163 (Purple). Images are representative of three images for individual patients. Scale bar, 10 μm. <strong>B–E</strong> The SASP Score analysis of cell components in indicated GBM single cell RNA-seq datasets (<strong>B</strong> <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235676" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE235676</a> <em>n</em> = 149048; <strong>C</strong> CGGA <em>n</em> = 4193; <strong>D</strong> <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84465" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE84465</a> <em>n</em> = 3571; <strong>E</strong> <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131928" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE131928</a> <em>n</em> = 7930; Left and middle: The tSNE/UMAP plot (Left) and corresponding SASP Score profile (Middle) in indicated cell populations according to indicated single-cell GBM dataset; Right: Enrichment of SASP Score in the indicated cell types from indicated single-cell GBM datasets).</p></figcaption></figure></section><section id="Sec31"><h3 class="pmc_sec_title">Pharmacological screening based on SASP Score identifies GDC-0879 as a potent SASP inhibitor</h3>
<p id="Par40">Considering the involvement of SASP activation indicated by the elevation of established SASP score in the malignant progression of IDH wt glioma, we next sought to screen the potential inhibitor of SASP with the SASP Score, which may help the development of strategy improving the therapeutic response of glioma. To better elucidate the therapeutic opportunities and identify the small molecular candidates targeting SASP in glioma, we interrogated drug screening data from Cancer Therapeutic Response Portal (CTRP, <a href="http://www.broadinstitute.org/ctrp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.broadinstitute.org/ctrp</a>) and CCLE dataset. The 538 drug candidates included in the screening were filtered by the correlation analysis based on delineating the sensitivity to the drug candidates associated with elevated SASP Scores in 30 glioma cell lines (AUC values, the area under the dose response curve, and smaller AUC values indicate greater sensitivity to the drug candidate) [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. We identified 31 candidates significantly associated with elevated SASP score (<em>P</em> &lt; 0.05). Notably, only three candidates (Carboplatin, SGX523, and GDC-0879) were negatively correlated with the elevation of established SASP score among 538 small molecules (Fig. <a href="#Fig5" class="usa-link">5A</a> and Table <a href="#MOESM1" class="usa-link">S14</a>). This indicates that carboplatin, SGX523 and GDC-0879 restrain the elevation of SASP Score and may serve as potential SASP inhibitors in glioma. Considering the side effects of carboplatin on bone marrow, liver, and renal functions, as well as the previously reported nephrotoxicity of SGX523 leading to its failure in clinical trials and the association of SGX523 metabolites with clinically observed obstructive nephropathy [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>], we selected GDC-0879 as the candidate for further investigation (Fig. <a href="#Fig5" class="usa-link">5A</a> and Table <a href="#MOESM1" class="usa-link">S14</a>).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5. Screening of small molecules identifies GDC-0879 as a potential SASP inhibitor effectively reducing GBM cell proliferation in vitro.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334699_41419_2025_7915_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd59/12334699/0d2af5e6d479/41419_2025_7915_Fig5_HTML.jpg" loading="lazy" id="d33e1512" height="999" width="728" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Small molecule screening implicating GDC-0879 as a potential SASP inhibitor in glioma cells (The screening data including 583 compounds and 30 glioma cell lines were obtained from The Cancer Therapeutics Response Portal (CTRP, <a href="http://www.broadinstitute.org/ctrp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.broadinstitute.org/ctrp</a>) and glioma cell line information was extracted from the Cancer Cell Line Encyclopedia (CCLE) project; AUC was used to represent drug response, in which a small value indicates sensitive in contrast to a large value indicating resistant. Spearman analysis of CTRP drug sensitivity (AUC values) and SASP Scores was calculated to rank the small molecular drug candidates. <strong>B</strong> The analysis of PGC62 (Left) and GSC0117 (Right) samples treated with or without GDC-0879 (10 µM treatment for 48 h), indicating significantly reduced SASP Score accompanied with GDC-0879 administration (<em>n</em> = 3). <strong>C</strong> Heatmap analysis showing that reduced SASP Score indicated restrained expression of SASP-associated genes. <strong>D</strong> GO analysis of RNA-seq data obtained from indicated control and GDC-0879 treated GBM cell samples (Left: PGC62, right: GSC0117). <strong>E</strong> GSEA analysis showing that GDC-0879 treatment of GBM cells significantly reduced the enrichment of the gene set associated with the activation of MAPK signaling pathway. <strong>F</strong> The comparison analysis of MAPK scores according to RNA-seq data obtained from indicated control and GDC-0879 treated GBM cell samples (Left: PGC62, right: GSC0117; <em>n</em> = 3, <em>t</em>-test). <strong>G</strong> The schematic graph showing the co-culture method of GBM cells with GDC-0879 treatment (Upper chamber) and untreated GBM cells (Lower chamber). <strong>H</strong> MTS assays of indicated GBM cells with or without GDC-0879 treatment (Vehicle: PGC62 or GSC0117 alone; DMSO: PGC62 or GSC0117 cocultured with DMSO pretreated PGC62 or GSC0117; GDC-0879: PGC62 or GSC0117 cocultured with GDC-0879 pretreated PGC62 or GSC0117; <em>n</em> = 3, one-way ANOVA). <strong>I</strong>, <strong>J</strong> Representative images (<strong>I</strong>) and analysis (<strong>J</strong>) of Transwell invasion assays of indicated GBM cell samples (<em>n</em> = 3, <em>t</em>-test). Scale bar, 50 μm. (ns not significant, * <em>P</em> &lt; 0.05, ** <em>P</em> &lt; 0.01, *** <em>P</em> &lt; 0.001, **** <em>P</em> &lt; 0.0001).</p></figcaption></figure><p id="Par41">Indeed, GDC-0879 exhibited a smaller and significant <em>R</em> value than well-known SASP inhibitors, Epigallocatechin Gallate and Ruxolitinib (Fig. <a href="#MOESM1" class="usa-link">S10A</a>). According to in vitro IC50 analysis with PGC62 and GSC0117, GDC-0879 has the smallest IC50 (PGC62: 11.76 μM and GSC0117: 13.56 μM) than Epigallocatechin Gallate (PGC62: 27.83 μM and GSC0117: 29.93 μM), Ruxolitinib (PGC62: 44.19 μM and GSC0117: 42.23 μM), and Rapamycin (PGC62: 14.75 μM and GSC0117: 18.95 μM, another SASP inhibitor) (Fig. <a href="#MOESM1" class="usa-link">S10B, C</a>) [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>–<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Additionally, doxorubicin-induced senescent GBM cells were more sensitive to GDC-0879 treatment compared to control cells (Fig. <a href="#MOESM1" class="usa-link">S10D, E</a>). After treating two doxorubicin-induced senescence GBM cells (PGC62 and GSC0117) with 10 μM GDC-0879, we observed a significant decrease in senescent SA-β-gal staining and a significant downregulation of P21 mRNA expression (Fig. <a href="#MOESM1" class="usa-link">S10F–I</a>). Additionally, RT-qPCR demonstrated that GDC-0879 treatment (10 μM) not only induced a significant reduction in mRNA expression of the SASP-related genes in senescent GBM cells (IL-6, IL1α, IL1β, TNFα, MMP3, CXCL10, and CCL2; Fig. <a href="#MOESM1" class="usa-link">S10H, I</a>), but also exhibited a more efficient inhibition on mRNA expression of SASP cytokines (IL1α, IL1β, TNFα, and CXCL10) than Epigallocatechin Gallate, Ruxolitinib, and Rapamycin at their IC50 concentration (Fig. <a href="#MOESM1" class="usa-link">S10J, K</a>). This indicated a potentially stronger inhibitory effect of GDC-0879 on SASP activation than these SASP inhibitors. The subsequent RNA-seq detection disclosed a decreased SASP Score induced by GDC-0879 treatment (Fig. <a href="#Fig5" class="usa-link">5B</a>). Heatmap analysis showed that reduced SASP Score efficiently reflected reduced SASP-associated gene expression in GBM cells (Fig. <a href="#Fig5" class="usa-link">5C</a>). Then, to dissect the potential mechanism related to GDC-0879 administration in GBM cells, we performed RNA-seq of primary GBM cell samples with GDC-0879 or control treatment. GO BP and KEGG analysis showed that GDC-0879 treatment mainly induced the enrichment in the BPs associated with apoptotic process and oncogenic signaling pathways like MAPK signaling pathway, Wnt signaling pathway, and NF-κB signaling pathway. (Figs. <a href="#Fig5" class="usa-link">5D, E</a> and <a href="#MOESM1" class="usa-link">S11A, B</a>). Then, GSEA and ten classical oncogenic signaling pathway [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>] score analysis constructed by “GSVA” R package together disclosed that GDC-0879 treatment significantly inhibited the activation of MAPK and Hippo signaling pathways in GBM cells (Table <a href="#MOESM1" class="usa-link">S14</a>). Since the analysis by GO, KEGG, and GSEA all supported GDC-0879 restraining MAPK signaling and GDC-0879 has been indicated to target this pathway, we chose MAPK for further investigation (Fig. <a href="#Fig5" class="usa-link">5D, E</a> and Table <a href="#MOESM1" class="usa-link">S14</a>). We constructed a MAPK score with MAPK signaling pathway gene set downloaded from the Molecular Signatures Database [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>] for evaluating the activation of MAPK pathway by GSVA, which demonstrated a significantly reduced MAPK score accompanied with GDC-0879 treatment (Fig. <a href="#Fig5" class="usa-link">5F</a>). Immunoblotting of MAPK signaling targets, including BRAF, ERK, p-ERK, P38, p-P38, JNK, and p-JNK in PGC62 and GSC0117 GBM cells with control, doxorubicin, or GDC-0879 treatment after doxorubicin induction further supported this observation (Fig. <a href="#MOESM1" class="usa-link">S11C</a>). These data support GDC-0879 functioning through MAPK pathway, while targeting SASP in GBM cells. Given the well-established role of aberrant activated MAPK signaling in mediating malignant cell proliferation, GDC-0879 may inhibit GBM cell growth through restraining MAPK signaling activation. Moreover, the data obtained from co-culture experiment of untreated GBM cells and Doxorubicin-induced senescence GBM cells with GDC-0879 pretreatment demonstrated that the proliferation abilities and invasion of untreated GBM cells induced by senescence GBM cells were significantly reduced by GDC-0879 pretreatment (Fig. <a href="#Fig5" class="usa-link">5G–J</a>). Meanwhile, GDC-0879 treatment at 10 μM significantly increased the proportion of apoptotic cells in senescence GBM cells samples induced by 200 and 100 nM Doxorubicin, compared to non-senescence GBM cells (as shown in Fig. <a href="#MOESM1" class="usa-link">S11D</a>, senescence in the two primary GBM cell lines induced by 100 nM Doxorubicin treatment was confirmed by SA-β-gal staining) (Fig. <a href="#MOESM1" class="usa-link">S11E, F</a>). Together, these results indicated GDC-0879 as a small molecule with SASP inhibition potential.</p></section><section id="Sec32"><h3 class="pmc_sec_title">GDC-0879 significantly restrains the enhanced proliferation and invasion of GBM cells induced by senescence TAMs presenting SASP</h3>
<p id="Par42">Since TAMs were one of the abundant cell populations with the highest SASP Score in GBM TME, we next employed two widely accepted macrophage models, THP-1 derived macrophages and mouse BMDMs, to examine whether GDC-0879 could efficiently suppress SASP activation in TAMs. The induction of cellular senescence in THP-1 derived macrophages and BMDMs by Doxorubicin (200 nM) was confirmed by SA-β-Gal staining (Fig. <a href="#MOESM1" class="usa-link">S12A, B</a>), which also led to a significant mRNA elevation of SASP genes in these cells (P21, IL6, IL1α, IL1β, TNFα, CXCL10, MMP3, CXCL10, and CCL2; Fig. <a href="#MOESM1" class="usa-link">S12C, D</a>). Similar to the observations of GDC-0879 on SASP of GBM cells (Fig. <a href="#MOESM1" class="usa-link">S10J, K</a>), qPCR revealed that GDC-0879 treatment efficiently inhibited the mRNA expression of SASP cytokines (IL1α, IL1β, TNFα, and CXCL10) in senescence-induced THP-1 derived macrophages than Epigallocatechin Gallate, Ruxolitinib, and Rapamycin at their IC50 concentration (Fig. <a href="#Fig6" class="usa-link">6A</a>). Besides, qPCR revealed a significantly reduced mRNA expression of P21, IL6, IL1α, IL1β, TNFα, CXCL10, MMP3, CXCL10, and CCL2 in THP-1 derived macrophages and BMDMs after GDC-0879 treated (Fig. <a href="#Fig6" class="usa-link">6B, C</a>). In addition, GDC-0879 treatment significantly decreased CD206 and CD163 mRNA expression in these cell samples, while increasing their CD86 and CD80 mRNA expression. This indicated a potential restraint triggered by GDC-0879 treatment on M2 polarization of TAMs (Fig. <a href="#MOESM1" class="usa-link">S12E</a>). Similarly, the enhanced proliferation abilities of GBM cells induced by the co-culture of Doxorubicin-induced senescence THP-1 derived macrophages and BMDMs were efficiently decreased by 10 μM GDC-0879 treatment (Fig. <a href="#Fig6" class="usa-link">6D, F, and H</a>). Moreover, the co-culture of GBM cells with macrophages pre-treated with Doxorubicin (200 nM) or GDC-0879 (10 μM) showed that Doxorubicin-induced senescence THP-1 derived macrophages and BMDMs significantly enhanced the migration and invasion of GBM cells, which could be reversed by GDC-0879 (Fig. <a href="#Fig6" class="usa-link">6E, G, and I</a> and <a href="#MOESM1" class="usa-link">S12F</a>). Thus, it is reasonable to conclude that GDC-0879 not only significantly reduced the M2 polarization of TAMs, but also limited the promotive effect of SASP factors from TAMs on GBM cell migration, invasion, and proliferation in vitro.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6. GDC-0879 treatment efficiently reduces macrophage M2 polarization.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334699_41419_2025_7915_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd59/12334699/d11aab46bd17/41419_2025_7915_Fig6_HTML.jpg" loading="lazy" id="d33e1705" height="1000" width="692" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> qPCR analysis of indicated marker (IL1α, IL1β, TNF-α, and CXCL10) mRNA in THP1-derived senescent macrophage samples induced by Doxorubicin and then treated with GDC-0879, Epigallocatechin Gallate, Ruxolitinib, and Rapamycin at their IC50 concentration (<em>n</em> = 3, <em>t</em>-test). <strong>B</strong>, <strong>C</strong> RT-qPCR analysis of indicated SASP marker genes in THP-1 (<strong>B</strong>) and mouse BMDMs (<strong>C</strong>) derived senescent macrophages induced by Doxorubicin (200 nM) and then with or without GDC-0879 treatment (10 μM) (<em>n</em> = 3, <em>t</em>-test). <strong>D</strong> MTS assays of PGC62 cell samples cocultured with control or Doxorubicin pretreated THP-1 derived macrophages with or without GDC-0879 treatment (Vehicle: PGC62 alone; DMSO: PGC62 cocultured with DMSO pretreated THP-1 derived macrophages; Doxorubicin: PGC62 cells cocultured with 200 nM Doxorubicin pretreated THP-1 derived macrophages; GDC-0879: PGC62 cocultured with THP-1 derived macrophages pretreated with 200 nM Doxorubicin and then treated with 10 μM GDC-0879; <em>n</em> = 3, one-way ANOVA). <strong>E</strong> Representative images (Left) and analysis (Right) of Transwell invasion (Upper) and migration (Lower) assays of PGC62 cell samples with the coculture of control or Doxorubicin (200 nM) pretreated THP-1 derived macrophages with or without GDC-0879 treatment (10 μM) (<em>n</em> = 3, one-way ANOVA). Scale bar, 50 μm. <strong>F</strong> MTS assays of indicated GSC0117 cocultured with control (DMSO) or Doxorubicin (200 nM) pretreated THP-1 derived macrophages with or without GDC-0879 treatment (10 μM) (Vehicle: GSC0117 alone; DMSO: GSC0117 cocultured with DMSO pretreated THP-1 derived macrophages; Doxorubicin: GSC0117 cocultured with Doxorubicin pretreated THP-1 derived macrophages; GDC-0879: GSC0117 cocultured with THP-1 derived macrophages pretreated with 200 nM Doxorubicin and then treated with 10 μM GDC-0879; <em>n</em> = 3, one-way ANOVA). <strong>G</strong> Representative images (Left) and analysis (Right) of Transwell invasion (Upper) and migration (Lower) assays of GSC0117 cell samples with the coculture of control or Doxorubicin (200 nM) pretreated THP-1 derived macrophages with or without GDC-0879 treatment (10 μM) (<em>n</em> = 3, one-way ANOVA). Scale bar, 50 μm. <strong>H</strong> MTS assays of GL261 cells cocultured with mouse BMDMs with indicated pre-treatment (Vehicle: GL261 alone; DMSO: GL261 cocultured with mouse BMDMs pretreated with DMSO; Doxorubicin: GL261 cocultured with mouse BMDMs pretreated with 200 nM Doxorubicin; GDC-0879: GL261 cocultured with mouse BMDMs pretreated with 200 nM Doxorubicin and then treated with 10 μM GDC-0879; <em>n</em> = 3, one-way ANOVA). <strong>I</strong> Representative images (Left) and analysis (Right) of Transwell invasion (Upper) and migration (Lower) assays of GL261 cells cocultured with control (DMSO) or Doxorubicin (200 nM) pretreated mouse BMDMs with or without GDC-0879 treatment (10 μM), respectively (<em>n</em> = 3, one-way ANOVA). Scale bar, 50 μm. (ns not significant, * <em>P</em> &lt; 0.05, ** <em>P</em> &lt; 0.01, *** <em>P</em> &lt; 0.001, **** <em>P</em> &lt; 0.0001).</p></figcaption></figure></section><section id="Sec33"><h3 class="pmc_sec_title">GDC-0879 significantly reduces the tumorigenicity of GBM cells in vivo and improves their response to PD1 blockade</h3>
<p id="Par43">Since we identified the involvement of SASP in mediating the dysregulated immune responses and contributing to the immunosuppressive TME of GBM, we next sought to examine whether GDC-0879 could restrain GBM SASP in vivo and sensitize them to immunotherapy like ICB. Somatic mutations have been implicated as a predictor of cancer response to immunotherapy and tumors with high mutation burden are considered to have higher immunogenicity and therefore may actively respond to ICB, due to their increased neoantigen burden [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. After stratified TCGA IDH wt glioma sample with the median value of SASP Score, in terms of somatic mutations, the mutation rate was 78.72% in low SASP Score group, higher than that in high SASP Score group (67.37%) (Fig. <a href="#MOESM1" class="usa-link">S13A, B</a>). This suggested that immunotherapy may bring more benefits to patients with low SASP Score. Then, the immunotherapy response and survival analysis with three cancer transcriptomic cohorts receiving ICB, including melanoma (Fig. <a href="#MOESM1" class="usa-link">S13C</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78220" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE78220</a>, <em>n</em> = 28, with anti-PD1; Fig. <a href="#MOESM1" class="usa-link">S13D</a>, Van-allen, <em>n</em> = 42, with anti-CTLA4) and metastatic urothelial cancer (Fig. <a href="#MOESM1" class="usa-link">S13E</a>, IMvigor210, <em>n</em> = 348, with anti-PD-L1) demonstrated that the SASP Score may efficiently stratify the patients’ response to anti-PD1 (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78220" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE78220</a>) instead of other two ICB strategy [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Similarly, SASP Score grouping distinguished patients’ survival in <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78220" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE78220</a> (with anti-PD1, Fig. <a href="#MOESM1" class="usa-link">S13F</a>), instead of the other two cohorts treated with anti-PD-L1 and anti-CTLA4, respectively (Fig. <a href="#MOESM1" class="usa-link">S13G, H</a>). The analysis of GBM treated with anti-PD1 (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235676" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE235676</a>) based on present SASP Score indicated that SASP Score was more enriched in the cell samples from GBM patients who did not respond to PD1 blockade (Fig. <a href="#MOESM1" class="usa-link">S14A, B</a>) [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Therefore, we sought to examine whether GDC-0879 treatment could improve GBM response to PD1 blockade, while clarifying the efficacy of GDC-0879 strategy on GBM progression in vivo. Intracranial SB mGSC transplantation C57BL/6 immune competent mice model was employed to conduct GBM orthotopic xenograft experiments. The administration of anti-PD1 in tumor-bearing mice based on the method described by previous studies [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>, <a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. The application of GDC-0879 also followed the strategy recommended by published reports [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>, <a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. (Fig. <a href="#Fig7" class="usa-link">7A</a>). Indeed, GDC-0879 monotherapy was effective in prolonging the survival of mice, while anti-PD1 therapy didn’t bring significant survival benefit, and the combination therapy brought a significantly better survival benefit than GDC-0879 alone (Fig. <a href="#Fig7" class="usa-link">7B</a>). GDC-0879 not only limited the proliferation of SB mouse GBM cells in vivo, but also significantly improved the effectiveness of anti-PD1 immunotherapy (Fig. <a href="#Fig7" class="usa-link">7B, C</a>). Consistent with the results obtained from in vitro assays (Fig. <a href="#MOESM1" class="usa-link">S10H, I</a>), IHC staining disclosed a significantly suppressed expression of senescence marker P21 and SASP cytokines like IL6 and IL1β in tumor samples, regardless of GDC-0879 mono- or combined therapy with anti-PD1 (Fig. <a href="#Fig7" class="usa-link">7D</a>). This suggested that GDC-0879 significantly reduces senescence cells as well as SASP factor secretion in GBM. Both of GDC-0879 mono- and combined therapy with anti-PD1 significantly increased the IHC staining intensity of cleaved-caspase 3 in these samples, indicating the increased apoptotic cell ratio induced by GDC-0879 treatment (Fig. <a href="#Fig7" class="usa-link">7D</a>). IF analysis further disclosed that GDC-0879 treatment reduced the number of senescent cells (identified with γ-H2AX, and P21 positive expression, and Lamin B1 negative expression). Moreover, both senescence GBM cells (identified with GFAP, γ-H2AX, and P21 positive, and LaminB1 negative expression) and TAMs (identified with IBA1, γ-H2AX, and P21 positive, and Lamin B1 negative expression) were reduced by GDC-0879 (Fig. <a href="#Fig7" class="usa-link">7E</a>). The combination of GDC-0879 and PD1 blockade led to an increase in CD3+ and CD8+ lymphocytes (Fig. <a href="#Fig7" class="usa-link">7D</a>), which suggested that GDC-0879 and combination treatment of GDC-0879 and anti-PD1 improved T cell antitumor immunity.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7. GDC-0879 treatment significantly reduces GBM cell tumorigenicity and improves their response to PD1 blockade.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334699_41419_2025_7915_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd59/12334699/9a0f6349b28a/41419_2025_7915_Fig7_HTML.jpg" loading="lazy" id="d33e1858" height="1000" width="714" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> The schematic graph showing the administration method of indicated treatments in SB mouse GBM cell derived intracranial tumor-bearing mouse models. Figure 7A was Created in BioRender. <strong>B</strong> Survival plots of mice intracranially transplanted with SB GBM cells and then receiving indicated treatment shown in Fig. 7A (Control: receiving a single oral dose of 0.5% methylcellulose/0.2% Tween 80 (MCT) and IgG2b isotype control; GDC-0879: GDC-0879 (100 μg/g body weight) in MCT was orally administered by gavage daily from 7th to 21st day; Anti-PD1: Anti-PD1 antibody (10 μg/g body weight) was injected intraperitoneally on the 5th, 8th, and 11th day after the intracranial implantation of SB GBM cells; Combined treatment: treated with GDC-0879 and anti-PD1; Log-rank test, <em>n</em> = 6). <strong>C</strong> Representative H&amp;E staining images of brain sections from indicated mice groups on day 21 after intracranial transplantation of SB mouse GBM cells. <strong>D</strong> Representative immunohistochemical staining images and analysis of P21, IL6, IL1β, C-caspase-3 (cleaved Caspase-3), CD3, CD4, and CD8 in SB intracranial xenograft sections from indicated mice groups (<em>n</em> = 3, one-way ANOVA). Scale bar, 25 μm. <strong>E</strong> Representative immunofluorescence images of DAPI (Dark blue), P21 (Red), γ-H2AX (Orange), Lamin B1 (Yellow), GFAP (Green), and IBA1 (Cyan) in SB intracranial xenograft sections from indicated mice groups (<em>n</em> = 3, <em>t</em>-test). Scale bar, 10 μm. <strong>F</strong> The ratio of cells with positive expression of GFAP and cleaved caspase 3, and IBA1 and cleaved caspase 3 treated by GDC-0879 treatment in SB intracranial xenograft sections from indicated mice groups (<em>n</em> = 3, <em>t</em>-test). (ns not significant, * <em>P</em> &lt; 0.05, ** <em>P</em> &lt; 0.01, *** <em>P</em> &lt; 0.001, **** <em>P</em> &lt; 0.0001).</p></figcaption></figure><p id="Par44">GL261-bearing C57BL/6 immune competent mice model was also employed to conduct GBM orthotopic xenograft experiments, and treated mice with anti-PD1 antibody, GDC-0879, and the combination of these two strategies, respectively (Fig. <a href="#MOESM1" class="usa-link">S15A</a>). Although both the administration of anti-PD1 and GDC-0879 monotherapy effectively prolonged mice survival, the combination strategy brought a significantly better survival benefit than GDC-0879 and anti-PD1 alone (Fig. <a href="#MOESM1" class="usa-link">S15B</a>). GDC-0879 treatment restrained the orthotopic proliferation of GL261 cells (Fig. <a href="#MOESM1" class="usa-link">S15C</a>) and reduced the IHC staining intensity of Ki67 in orthotopic xenografts (Fig. <a href="#MOESM1" class="usa-link">S15D</a>). This reflected its capability to reduce GBM cell tumorigenicity in vivo, while its combination with anti-PD1 treatment further strengthened this effect (Fig. <a href="#MOESM1" class="usa-link">S15D</a>). IHC staining disclosed a significantly suppressed expression of senescence marker P21 and SASP cytokines like IL6 and IL1β in tumor samples, regardless of GDC-0879 mono- or combined therapy with anti-PD1 (Fig. <a href="#MOESM1" class="usa-link">S15D</a>). Both of GDC-0879 mono- and combined therapy with anti-PD1 significantly increased the IHC staining intensity of cleaved-caspase 3 in these samples, indicating the increased apoptotic cell ratio induced by GDC-0879 treatment (Fig. <a href="#MOESM1" class="usa-link">S15D</a>). IF analysis disclosed that GDC-0879 treatment reduced the number of senescent cells (identified with γ-H2AX, and P21 positive expression, and Lamin B1 negative expression). Moreover, both senescent glioma cells (identified with GFAP, γ-H2AX, and P21 positive, and Lamin B1 negative expression) and TAMs (identified with IBA1, γ-H2AX, and P21 positive, and Lamin B1 negative expression) were reduced by GDC-0879 (Fig. <a href="#MOESM1" class="usa-link">S15E</a>). The combination of GDC-0879 and PD1 blockade led to an increase in CD3+ lymphocytes (Fig. <a href="#MOESM1" class="usa-link">S15D</a>), and GDC-0879 and combination treatment group samples demonstrated an enrichment of CD4+ and CD8 + T cells, which suggested that GDC-0879 and combination treatment of GDC-0879 and anti-PD1 improved T cell antitumor immunity (Fig. <a href="#MOESM1" class="usa-link">S15D</a>). IF analysis disclosed that GDC-0879 treatment increases apoptosis ratios of GBM cells and macrophages in SB and GL261 mice orthotopic xenograft (Figs. <a href="#Fig7" class="usa-link">7F</a> and <a href="#MOESM1" class="usa-link">S16A–C</a>). Meanwhile, the detection of reduced CD206+ and elevated CD86+ cell ratio in GDC-0879 treatment group suggested that GDC-0879 reduced the infiltration of M2-like TAMs. This trend was further strengthened by the combination strategy with anti-PD1 (Fig. <a href="#MOESM1" class="usa-link">S17A, B</a>). FACS analysis revealed that combined treatment had significantly improved MHCII+ cell infiltration, while CD206+ cell infiltration was decreased, indicating that GDC-0879 suppressed the infiltration of M2-like TAMs (Fig. <a href="#MOESM1" class="usa-link">S17C, D</a>). Moreover, the combination of GDC-0879 and anti-PD1 didn’t bring significant liver and renal toxicity in tumor-bearing mice (Fig. <a href="#MOESM1" class="usa-link">S18A, B</a>), which supports the potential clinical translation feasibility of this treatment strategy. In addition, IHC analysis of brain sections of GL-261 and SB mouse GBM cell-derived intracranial tumor-bearing mice demonstrated that GDC-0879 treatment significantly reduced the staining intensities of the MAPK signaling targets, including BRAF, ERK, p-ERK, P38, p-P38, JNK, and p-JNK (Fig. <a href="#MOESM1" class="usa-link">S19A, B</a>), supporting the potential role of GDC-0879 functioning through MAPK pathway, while targeting SASP in GBM. Besides, Tumor Treating Field (TTF) treatment is a recent progress in GBM therapeutics functioning through inhibiting the mitosis of GBM cells and inducing senescence in these cells [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. The analysis of RNA-seq data obtained from a recent study disclosed a significant elevation of SASP score in GBM samples with TTF treatment in comparison with control samples (Fig. <a href="#MOESM1" class="usa-link">S20A</a>). Together, these data support GDC-0879 as a small molecule targeting SASP in GBM, which brings survival benefits in mice preclinical models and improves their responses to anti-PD1.</p></section></section><section id="Sec34"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par45">While senescence induces the proliferation arrest of cancer cells and non-malignant cells in the TME, it plays ambivalent roles in oncogenesis and may contribute to cancer progression through the intercellular communication mechanism, SASP [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. In present study, we generate a SASP gene set and establish an SASP Score with ssGSEA method, which effectively reflects SASP activation status in glioma. Then, through an integrated transcriptomic analysis, we find that IDH wt glioma exhibits an elevated SASP Score than IDH mutant glioma, which serves as an important feature for the progression of IDH wt glioma. Screening based on the SASP Score identify a small molecular candidate for SASP inhibition, GDC-0879, which administration decreases the tumorigenicity of GBM cells and improves their responses to anti-PD1.</p>
<p id="Par46">A recent study defined a GBM senescence signature by calculating a ssGSEA senescent Z-score corresponding to 31 DEGs, and single-cell data analysis showed that mouse senescence signature was conserved in patient GBM [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. The 91 gene candidates included in our gene panel could be classified into the following two broad categories: senescence markers and SASP factor-encoding genes. Considering the context-dependent nature of senescence, the senescence markers included in our panel are not only from the gene encoding different hallmarks of senescence, but also cover the senescence markers more common in CNS. The SASP factor genes included in our gene set cover the genes encoding chemokines, growth factors and regulators, interleukins, proteases and regulators, soluble or shed receptors or ligands, inflammatory factors, and classical senescence markers (Table <a href="#MOESM1" class="usa-link">S1</a>). This SASP scoring method could be applied for bulk and scRNA-seq data analysis to identify cells with high levels of SASP factor encoding gene expression. Moreover, our gene set comprised the genes encoding the regulators of senescence characteristics, especially a focused overview of the most prominent SASP features contributing to cancer progression, as well as covering the classical senescence markers of CNS, which allows us to construct a SASP scoring model that quantifies the level of senescence cells and SASP activation in glioma and minimized the possibility of confounding with phenotypic features other than non-senescence [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>–<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]. The effectiveness of our SASP gene set was validated in our own CMU GBM dataset, as well as in other four large-size glioma datasets, which supports the potential of our work in assessing GBM SASP status. Indeed, our SASP Score has the potential serving as a more applicable quantification and evaluation system for SASP in glioma compared to previous senescence models constructed in glioma [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>–<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>] through combining the senescence marker genes with SASP factor encoding genes in Table <a href="#MOESM1" class="usa-link">S1</a>. Meanwhile, the incorporation of multiple senescence markers in current gene panel would be conducive for overcoming the limitation of single senescence marker like CDKN2A, which presents insufficient expression abundance at transcriptomic level, especially in scRNA-seq [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. The integration of genes encoding classical senescence markers, especially markers more common in CNS, make our panel more suitable for the detection of SASP in glioma, instead of other inflammation responses. For example, in the comparison of our SASP Score with 4 other senescence signatures [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>–<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>], only our SASP Score consistently shows significant upregulation in the 9 senescence induction models (Fig. <a href="#MOESM1" class="usa-link">S1A</a>), which supports the validity of our signature in SASP evaluation. Another interesting finding is that we observed that primary GBM cell PGC62 exhibits a higher SASP Score compared GSC0117 cultured in serum-free medium. This may be due to the genetic background difference between samples. However, the comparison of paired GSC and serum-induced DGC samples also disclosed a significantly elevated SASP Score in DGC samples than GSC (Data not shown). Considering that GSC presents stronger tumorigenicity than paired serum-induced DGC, it is worthy for further investigation whether there exists differential SASP activation between GSC and DGC population and their roles in facilitating GBM progression. Furthermore, it is worth noting that pro-inflammatory secreted SASP factors also function during inflammatory response. The inflammation characteristics and context-dependent nature of SASP may impact the evaluation fidelity of present SASP panel despite the incorporation of multiple senescence marker encoding genes in current panel reduces the probability of confounding with other inflammatory responses.</p>
<p id="Par47">Previously, it has been revealed that the constitutions of cancer-infiltrating immune cells and the interaction between these cells and malignant cells varied with the genetic background of cancers and the composition of accompanied SASP [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Interestingly, current study identified cancer cells and TAMs as the most abundant cell population presenting SASP in GBM TME. The enrichment of SASP Score in IDH wt glioma may be a reflection of IDH wt glioma harboring more intra-tumoral macrophages in TME compared to IDH mutation tumors with more microglia. scRNA-seq implicates that GBM cell senescence is a heterogeneous phenotype. The enrichment of SASP score in MES-like cellular state of GBM cells. This may reflect the close association of MES identity or cellular state in malignant cells with stress responses. While senescent cancer cells present proliferation arrest, they facilitate the proliferation of non-senescent malignant cells by paracrine signals of SASP. Senescence cells secrete a diversity of bioactive proteins, which contributes to tumorigenesis through the context-dependent mechanisms and may reinforce the senescence program in an autocrine manner.</p>
<p id="Par48">Another finding in present work is that SASP potentially impacts GBM response to anti-PD1 therapy and GDC-0879 was identified as a small molecular candidate targeting SASP in glioma by SASP inhibitor screening in glioma cells based on current SASP Score. GDC-0879 was primarily reported as a BRAF mutant inhibitor, and may exert opposing cellular context-dependent functions on tumor growth. GDC-0879 showed specific inhibition on cancers with BRAF(V600E) mutation through blocking MAPK signaling, a common oncogenic pathway [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>, <a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>], in contrast to enhancing tumor growth in KRAS mutant and RAS/RAF wild-type tumors like melanoma and lung cancer by exhibiting RAS-dependent activation on RAF-MEK-ERK pathway through direct conformational effects on RAF kinase domain [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. Additionally, GDC-0879, as a highly selective small molecule inhibitor of RAF, has variable functions on the activation of RAF and MEK in malignant cells [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. The inhibition of GDC-0879 on MEK restrains the proliferation of cancer cell lines carrying wild-type BRAF with different KRAS status (81% KRAS mutant, 38% KRAS wild-type) [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. It has been reported that physiological activation of the MAPK pathway is caused by stimulation of ligand-dependent tyrosine kinase transmembrane receptors (RTKs), which homo- or hetero-dimerize leading to the phosphorylation and activation of a downstream cascade involving the RAS, RAF kinase, MEK1/2, and ERK. Activated ERK proteins translocate to the nucleus, where they phosphorylate and regulate multiple transcription factors, modulating downstream target transcription. The activation and transduction of this signaling pathway drive cell proliferation, differentiation, survival, or senescence [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. Indeed, sustained activation of the RAS/MAPK signaling pathway leads to cell proliferation arrest by affecting p53 and/or p16 activities [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. After observing the restriction effect of GDC-0879 on the proliferation of two primary GBM cell lines in vitro, we assessed the therapeutic effect of GDC-0879 in vivo. We firstly employed GL261 derived immunocompetent murine orthotopic xenograft model, which is widely used for evaluating immunotherapy efficiency in GBM. The administration of GDC-0879 significantly extended the survival of mouse GL261 GBM preclinical model and improved their response to anti-PD1. Given that GL261 is recognized as a hypermutated GBM model [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>], we further utilized SB mouse GBM cells derived murine orthotopic tumor model established by SB transposon technique to examine the therapeutic efficiency of GDC-0879, which is considered to more reliably recapitulate human GBM characteristics compared to GL261 model [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Similarly, GDC-0879 treatment brought substantial survival benefit to SB tumor-bearing mice and ameliorated their sensitivities to anti-PD1. To date, the application of GDC-0879 in GBM treatment remains quite limited. In present study, we observed significant activation of MAPK signaling pathway induced by doxorubicin treatment, which could be efficiently inhibited by the application of GDC-0879. This provides a potential explanation for GDC-0879 mediated SASP inhibition in GBM. Since the context-dependent mechanism has been indicated for GDC-0879 application in cancer, the further investigation is required to clarify the direct interacting partners and downstream effectors of GDC-0879 in GBM cells and the cell populations affected by GDC-0879 in GBM TME. We also observed a significant inhibitory effect of GDC-0879 on the activation of HIPPO pathway through the GSEA analysis (Table <a href="#MOESM1" class="usa-link">S15</a>), which is an important aspect for subsequent research. Moreover, the application of GDC-0879 significantly reversed the pro-tumorigenic TAMs to pro-inflammatory phenotype, which indicated its potential to unbound the suppression of TAMs on immunosurveillance in TME and enhanced cytotoxic CD8 + T cell infiltration, which improved cancer response to anti-PD1. Moreover, with the development of neoadjuvant immunotherapy, the importance of time-setting of immune therapeutic strategy is increasingly recognized by researchers. Since GDC-0879 sensitizes GBM to anti-PD1, the optimization of current administration setting on applicating GDC-0879 before anti-PD1 may further sensitize GBM to PD1 blockade, which is worthy further investigation.</p>
<p id="Par49">TTF treatment, as a strategy recently adopted into the standards of care in GBM therapy, has been reported to induce senescence in GBM cells in mediating its anti-cancer impacts [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. The analysis of RNA-seq data obtained from a recent report [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>] on the potential mechanism of TTF treatment against GBM, which revealed GBM samples with TTF treatment demonstrating an elevation of SASP Score compared to control samples. This supported TTF treatment, inducing GBM senescence, while achieving therapeutic benefits. However, cellular senescence is a complex multifaced biological process. It has a dual effect on cancer progression. Due to the notorious heterogenous nature of GBM, malignant cells exhibit varying response to TTF. While senescence of malignant cells is conducive to the control of tumor progression through inducing proliferation arrest, it may facilitate cancer progression through SASP by affecting the functions and behaviors of TME components, including adjacent malignant cells survival from TTF and immune cells through paracrine effects [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. The combination of small molecule targeting SASP like GDC-0879 and TTF treatment may have the potential to disrupt the delicate balance elaborately constructed by malignant cells and further bring therapeutic benefit to GBM patients receiving TTF therapy, which is worthy for further investigation.</p>
<p id="Par50">In summary, we provide a SASP Score with generating a SASP gene panel. The validation of this score in function assays and cancer senescence datasets demonstrates that it could efficiently reflect SASP activation. Additionally, our study highlights that IDH wt glioma exhibits a more active SASP phenotype compared to IDH mutant tumor and GBM exhibits a pro-tumorigenic context-dependent SASP activation, especially in malignant cells and TAMs. The screening with the SASP Score identified GDC-0879 as a small molecular SASP inhibitor improving the efficiency of anti-PD1 therapy in mice GBM preclinical model. The combination of SASP inhibition and anti-PD1 could be taken into account as a potential strategy for future clinical studies.</p></section><section id="Sec35"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12334699/bin/41419_2025_7915_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary figures</a><sup> (12.2MB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12334699/bin/41419_2025_7915_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary tables</a><sup> (419.2KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12334699/bin/41419_2025_7915_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Original File of Western Blot</a><sup> (1.2MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank the staff of Laboratory Animal Center of China Medical University. We also thank Figdraw (<a href="http://www.figdraw.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.figdraw.com</a>) for the assistance in creating Graphical abstract.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Y. Liu, A.H. Wu, and P. Cheng conceived and designed the study. Y. Liu, Y. Feng, L. Cheng, and Y. Xu performed experiments and collected data. Y. Liu performed the bioinformatics analysis. P. Cheng, Y. Liu, and A. H. Wu contributed to draft the manuscript. P. Cheng and A.H. Wu obtained fundings. All authors read and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was supported by the National Natural Science Foundation of China (no. 81872057 to P. Cheng, and no. U20A20380, 82472833, 81872054 to A. H. Wu).</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par51">The authors declare no competing interests.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p>Edited by Dr Maria Victoria Niklison Chirou.</p></div>
<div class="fn p" id="fn2"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div>
<div class="fn p" id="fn3"><p>These authors contributed equally: Yang Liu, Yuan Feng, Lin Cheng.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Anhua Wu, Email: ahwu@cmu.edu.cn.</p>
<p>Peng Cheng, Email: chengpeng@cmu.edu.cn.</p></section><section id="sec36"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s41419-025-07915-3.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Gasek NS, Kuchel GA, Kirkland JL, Xu M. Strategies for targeting senescent cells in human disease. Nat Aging. 2021;1:870–9.
</cite> [<a href="https://doi.org/10.1038/s43587-021-00121-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8612694/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34841261/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gasek%20NS,%20Kuchel%20GA,%20Kirkland%20JL,%20Xu%20M.%20Strategies%20for%20targeting%20senescent%20cells%20in%20human%20disease.%20Nat%20Aging.%202021;1:870%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Salam R, Saliou A, Bielle F, Bertrand M, Antoniewski C, Carpentier C, et al. Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma. Nat Commun. 2023;14:441.
</cite> [<a href="https://doi.org/10.1038/s41467-023-36124-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9883514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36707509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Salam%20R,%20Saliou%20A,%20Bielle%20F,%20Bertrand%20M,%20Antoniewski%20C,%20Carpentier%20C,%20et%20al.%20Cellular%20senescence%20in%20malignant%20cells%20promotes%20tumor%20progression%20in%20mouse%20and%20patient%20Glioblastoma.%20Nat%20Commun.%202023;14:441." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Schmitt CA, Wang B, Demaria M. Senescence and cancer - role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19:619–36.
</cite> [<a href="https://doi.org/10.1038/s41571-022-00668-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9428886/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36045302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmitt%20CA,%20Wang%20B,%20Demaria%20M.%20Senescence%20and%20cancer%20-%20role%20and%20therapeutic%20opportunities.%20Nat%20Rev%20Clin%20Oncol.%202022;19:619%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, et al. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro-Oncol. 2020;22:1073–113.
</cite> [<a href="https://doi.org/10.1093/neuonc/noaa106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7594557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32328653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wen%20PY,%20Weller%20M,%20Lee%20EQ,%20Alexander%20BM,%20Barnholtz-Sloan%20JS,%20Barthel%20FP,%20et%20al.%20Glioblastoma%20in%20adults:%20a%20Society%20for%20Neuro-Oncology%20(SNO)%20and%20European%20Society%20of%20Neuro-Oncology%20(EANO)%20consensus%20review%20on%20current%20management%20and%20future%20directions.%20Neuro-Oncol.%202020;22:1073%E2%80%93113." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Jackson CM, Choi J, Lim M. Mechanisms of immunotherapy resistance: lessons from glioblastoma. Nature Immunol. 2019;20:1100–9.
</cite> [<a href="https://doi.org/10.1038/s41590-019-0433-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31358997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jackson%20CM,%20Choi%20J,%20Lim%20M.%20Mechanisms%20of%20immunotherapy%20resistance:%20lessons%20from%20glioblastoma.%20Nature%20Immunol.%202019;20:1100%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>D’Ambrosio M, Gil J. Reshaping of the tumor microenvironment by cellular senescence: an opportunity for senotherapies. Dev Cell. 2023;58:1007–21.
</cite> [<a href="https://doi.org/10.1016/j.devcel.2023.05.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37339603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?D%E2%80%99Ambrosio%20M,%20Gil%20J.%20Reshaping%20of%20the%20tumor%20microenvironment%20by%20cellular%20senescence:%20an%20opportunity%20for%20senotherapies.%20Dev%20Cell.%202023;58:1007%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Cohn RL, Gasek NS, Kuchel GA, Xu M. The heterogeneity of cellular senescence: insights at the single-cell level. Trends Cell Biol. 2023;33:9–17.
</cite> [<a href="https://doi.org/10.1016/j.tcb.2022.04.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9812642/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35599179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cohn%20RL,%20Gasek%20NS,%20Kuchel%20GA,%20Xu%20M.%20The%20heterogeneity%20of%20cellular%20senescence:%20insights%20at%20the%20single-cell%20level.%20Trends%20Cell%20Biol.%202023;33:9%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Bowman RL, Wang Q, Carro A, Verhaak RG, Squatrito M. GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neuro-Oncol. 2017;19:139–41.
</cite> [<a href="https://doi.org/10.1093/neuonc/now247" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5193031/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28031383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bowman%20RL,%20Wang%20Q,%20Carro%20A,%20Verhaak%20RG,%20Squatrito%20M.%20GlioVis%20data%20portal%20for%20visualization%20and%20analysis%20of%20brain%20tumor%20expression%20datasets.%20Neuro-Oncol.%202017;19:139%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Van Allen EM, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science. 2015;350:207–11.
</cite> [<a href="https://doi.org/10.1126/science.aad0095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5054517/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26359337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Van%20Allen%20EM,%20Miao%20D,%20Schilling%20B,%20Shukla%20SA,%20Blank%20C,%20Zimmer%20L,%20et%20al.%20Genomic%20correlates%20of%20response%20to%20CTLA-4%20blockade%20in%20metastatic%20melanoma.%20Science.%202015;350:207%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Xu S, Luo C, Chen D, Tang L, Chen L, Liu Z. Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma. Cell Death Dis. 2022;13:721.
</cite> [<a href="https://doi.org/10.1038/s41419-022-05127-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9388668/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35982032/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20S,%20Luo%20C,%20Chen%20D,%20Tang%20L,%20Chen%20L,%20Liu%20Z.%20Whole%20transcriptome%20and%20proteome%20analyses%20identify%20potential%20targets%20and%20mechanisms%20underlying%20tumor%20treating%20fields%20against%20glioblastoma.%20Cell%20Death%20Dis.%202022;13:721." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Mei Y, Wang X, Zhang J, Liu D, He J, Huang C, et al. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. Nature Cancer. 2023;4:1273–91.
</cite> [<a href="https://doi.org/10.1038/s43018-023-00598-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37460871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mei%20Y,%20Wang%20X,%20Zhang%20J,%20Liu%20D,%20He%20J,%20Huang%20C,%20et%20al.%20Siglec-9%20acts%20as%20an%20immune-checkpoint%20molecule%20on%20macrophages%20in%20glioblastoma,%20restricting%20T-cell%20priming%20and%20immunotherapy%20response.%20Nature%20Cancer.%202023;4:1273%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 2019;178:835–49.e21.
</cite> [<a href="https://doi.org/10.1016/j.cell.2019.06.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6703186/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31327527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Neftel%20C,%20Laffy%20J,%20Filbin%20MG,%20Hara%20T,%20Shore%20ME,%20Rahme%20GJ,%20et%20al.%20An%20integrative%20model%20of%20cellular%20states,%20plasticity,%20and%20genetics%20for%20glioblastoma.%20Cell.%202019;178:835%E2%80%9349.e21." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Darmanis S, Sloan SA, Croote D, Mignardi M, Chernikova S, Samghababi P, et al. Single-cell RNA-seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma. Cell Rep. 2017;21:1399–410.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2017.10.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5810554/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29091775/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Darmanis%20S,%20Sloan%20SA,%20Croote%20D,%20Mignardi%20M,%20Chernikova%20S,%20Samghababi%20P,%20et%20al.%20Single-cell%20RNA-seq%20analysis%20of%20infiltrating%20neoplastic%20cells%20at%20the%20migrating%20front%20of%20human%20glioblastoma.%20Cell%20Rep.%202017;21:1399%E2%80%93410." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Zhao Z, Zhang KN, Wang Q, Li G, Zeng F, Zhang Y, et al. Chinese Glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients. Genomics Proteom Bioinforma. 2021;19:1–12.</cite> [<a href="https://doi.org/10.1016/j.gpb.2020.10.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8498921/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33662628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20Z,%20Zhang%20KN,%20Wang%20Q,%20Li%20G,%20Zeng%20F,%20Zhang%20Y,%20et%20al.%20Chinese%20Glioma%20Genome%20Atlas%20(CGGA):%20a%20comprehensive%20resource%20with%20functional%20genomic%20data%20from%20Chinese%20glioma%20patients.%20Genomics%20Proteom%20Bioinforma.%202021;19:1%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 2013;14:7.</cite> [<a href="https://doi.org/10.1186/1471-2105-14-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3618321/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23323831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?H%C3%A4nzelmann%20S,%20Castelo%20R,%20Guinney%20J.%20GSVA:%20gene%20set%20variation%20analysis%20for%20microarray%20and%20RNA-seq%20data.%20BMC%20Bioinforma.%202013;14:7." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Liu T, Zhu C, Chen X, Guan G, Zou C, Shen S, et al. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neuro Oncol. 2022;24:1113–25.
</cite> [<a href="https://doi.org/10.1093/neuonc/noac033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9248406/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35148413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20T,%20Zhu%20C,%20Chen%20X,%20Guan%20G,%20Zou%20C,%20Shen%20S,%20et%20al.%20Ferroptosis,%20as%20the%20most%20enriched%20programmed%20cell%20death%20process%20in%20glioma,%20induces%20immunosuppression%20and%20immunotherapy%20resistance.%20Neuro%20Oncol.%202022;24:1113%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, et al. De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Res. 2009;69:431–9.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-08-1800" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2701484/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19147555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wiesner%20SM,%20Decker%20SA,%20Larson%20JD,%20Ericson%20K,%20Forster%20C,%20Gallardo%20JL,%20et%20al.%20De%20novo%20induction%20of%20genetically%20engineered%20brain%20tumors%20in%20mice%20using%20plasmid%20DNA.%20Cancer%20Res.%202009;69:431%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8.
</cite> [<a href="https://doi.org/10.1006/meth.2001.1262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11846609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Livak%20KJ,%20Schmittgen%20TD.%20Analysis%20of%20relative%20gene%20expression%20data%20using%20real-time%20quantitative%20PCR%20and%20the%202(-Delta%20Delta%20C(T))%20Method.%20Methods.%202001;25:402%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Qiu Z, Zhao L, Shen JZ, Liang Z, Wu Q, Yang K, et al. Transcription elongation machinery is a druggable dependency and potentiates immunotherapy in glioblastoma stem cells. Cancer Discov. 2022;12:502–21.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-20-1848" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8831451/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34615656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu%20Z,%20Zhao%20L,%20Shen%20JZ,%20Liang%20Z,%20Wu%20Q,%20Yang%20K,%20et%20al.%20Transcription%20elongation%20machinery%20is%20a%20druggable%20dependency%20and%20potentiates%20immunotherapy%20in%20glioblastoma%20stem%20cells.%20Cancer%20Discov.%202022;12:502%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603–7.
</cite> [<a href="https://doi.org/10.1038/nature11003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3320027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22460905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barretina%20J,%20Caponigro%20G,%20Stransky%20N,%20Venkatesan%20K,%20Margolin%20AA,%20Kim%20S,%20et%20al.%20The%20cancer%20cell%20line%20encyclopedia%20enables%20predictive%20modelling%20of%20anticancer%20drug%20sensitivity.%20Nature.%202012;483:603%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Rees MG, Seashore-Ludlow B, Cheah JH, Adams DJ, Price EV, Gill S, et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol. 2016;12:109–16.
</cite> [<a href="https://doi.org/10.1038/nchembio.1986" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4718762/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26656090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rees%20MG,%20Seashore-Ludlow%20B,%20Cheah%20JH,%20Adams%20DJ,%20Price%20EV,%20Gill%20S,%20et%20al.%20Correlating%20chemical%20sensitivity%20and%20basal%20gene%20expression%20reveals%20mechanism%20of%20action.%20Nat%20Chem%20Biol.%202016;12:109%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Basu A, Bodycombe NE, Cheah JH, Price EV, Liu K, Schaefer GI, et al. An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell. 2013;154:1151–61.
</cite> [<a href="https://doi.org/10.1016/j.cell.2013.08.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3954635/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23993102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Basu%20A,%20Bodycombe%20NE,%20Cheah%20JH,%20Price%20EV,%20Liu%20K,%20Schaefer%20GI,%20et%20al.%20An%20interactive%20resource%20to%20identify%20cancer%20genetic%20and%20lineage%20dependencies%20targeted%20by%20small%20molecules.%20Cell.%202013;154:1151%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Marin I, Boix O, Garcia-Garijo A, Sirois I, Caballe A, Zarzuela E, et al. Cellular senescence is immunogenic and promotes antitumor immunity. Cancer Discov. 2023;13:410–31.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-22-0523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7614152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36302218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marin%20I,%20Boix%20O,%20Garcia-Garijo%20A,%20Sirois%20I,%20Caballe%20A,%20Zarzuela%20E,%20et%20al.%20Cellular%20senescence%20is%20immunogenic%20and%20promotes%20antitumor%20immunity.%20Cancer%20Discov.%202023;13:410%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Remmele W, Schicketanz KH. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract. 1993;189:862–6.
</cite> [<a href="https://doi.org/10.1016/S0344-0338(11)81095-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8302707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Remmele%20W,%20Schicketanz%20KH.%20Immunohistochemical%20determination%20of%20estrogen%20and%20progesterone%20receptor%20content%20in%20human%20breast%20cancer.%20Computer-assisted%20image%20analysis%20(QIC%20score)%20vs.%20subjective%20grading%20(IRS).%20Pathol%20Res%20Pract.%201993;189:862%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Becher B, Waisman A. T-helper cells: methods and protocols. Preface. Methods Mol Biol. 2014;1193:v–vi.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/25289419/" class="usa-link">PubMed</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Saha D, Martuza RL, Rabkin SD. Macrophage polarization contributes to glioblastoma eradication by combination immunovirotherapy and immune checkpoint blockade. Cancer Cell. 2017;32:253–67.e5.
</cite> [<a href="https://doi.org/10.1016/j.ccell.2017.07.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5568814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28810147/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saha%20D,%20Martuza%20RL,%20Rabkin%20SD.%20Macrophage%20polarization%20contributes%20to%20glioblastoma%20eradication%20by%20combination%20immunovirotherapy%20and%20immune%20checkpoint%20blockade.%20Cancer%20Cell.%202017;32:253%E2%80%9367.e5." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Fletcher-Sananikone E, Kanji S, Tomimatsu N, Di Cristofaro LFM, Kollipara RK, Saha D, et al. Elimination of radiation-induced senescence in the brain tumor microenvironment attenuates glioblastoma recurrence. Cancer Res. 2021;81:5935–47.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-21-0752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9724593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34580063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fletcher-Sananikone%20E,%20Kanji%20S,%20Tomimatsu%20N,%20Di%20Cristofaro%20LFM,%20Kollipara%20RK,%20Saha%20D,%20et%20al.%20Elimination%20of%20radiation-induced%20senescence%20in%20the%20brain%20tumor%20microenvironment%20attenuates%20glioblastoma%20recurrence.%20Cancer%20Res.%202021;81:5935%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50:W216–W21.
</cite> [<a href="https://doi.org/10.1093/nar/gkac194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9252805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35325185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sherman%20BT,%20Hao%20M,%20Qiu%20J,%20Jiao%20X,%20Baseler%20MW,%20Lane%20HC,%20et%20al.%20DAVID:%20a%20web%20server%20for%20functional%20enrichment%20analysis%20and%20functional%20annotation%20of%20gene%20lists%20(2021%20update).%20Nucleic%20Acids%20Res.%202022;50:W216%E2%80%93W21." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Xu L, Deng C, Pang B, Zhang X, Liu W, Liao G, et al. TIP: a web server for resolving tumor immunophenotype profiling. Cancer Res. 2018;78:6575–80.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-18-0689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30154154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20L,%20Deng%20C,%20Pang%20B,%20Zhang%20X,%20Liu%20W,%20Liao%20G,%20et%20al.%20TIP:%20a%20web%20server%20for%20resolving%20tumor%20immunophenotype%20profiling.%20Cancer%20Res.%202018;78:6575%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 2013;4:2612.
</cite> [<a href="https://doi.org/10.1038/ncomms3612" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3826632/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24113773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yoshihara%20K,%20Shahmoradgoli%20M,%20Mart%C3%ADnez%20E,%20Vegesna%20R,%20Kim%20H,%20Torres-Garcia%20W,%20et%20al.%20Inferring%20tumour%20purity%20and%20stromal%20and%20immune%20cell%20admixture%20from%20expression%20data.%20Nat.%20Commun.%202013;4:2612." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.
</cite> [<a href="https://doi.org/10.1186/s13059-017-1349-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5688663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29141660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aran%20D,%20Hu%20Z,%20Butte%20AJ.%20xCell:%20digitally%20portraying%20the%20tissue%20cellular%20heterogeneity%20landscape.%20Genome%20Biol.%202017;18:220." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17:218.
</cite> [<a href="https://doi.org/10.1186/s13059-016-1070-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5073889/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27765066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Becht%20E,%20Giraldo%20NA,%20Lacroix%20L,%20Buttard%20B,%20Elarouci%20N,%20Petitprez%20F,%20et%20al.%20Estimating%20the%20population%20abundance%20of%20tissue-infiltrating%20immune%20and%20stromal%20cell%20populations%20using%20gene%20expression.%20Genome%20Biol.%202016;17:218." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39:782–95.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2013.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24138885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bindea%20G,%20Mlecnik%20B,%20Tosolini%20M,%20Kirilovsky%20A,%20Waldner%20M,%20Obenauf%20AC,%20et%20al.%20Spatiotemporal%20dynamics%20of%20intratumoral%20immune%20cells%20reveal%20the%20immune%20landscape%20in%20human%20cancer.%20Immunity.%202013;39:782%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Suryadevara V, Hudgins AD, Rajesh A, Pappalardo A, Karpova A, Dey AK. et al. SenNet recommendations for detecting senescent cells in different tissues. Nat Rev Mol Cell Biol. 2024;25:1001–1023.
</cite> [<a href="https://doi.org/10.1038/s41580-024-00738-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11578798/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38831121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suryadevara%20V,%20Hudgins%20AD,%20Rajesh%20A,%20Pappalardo%20A,%20Karpova%20A,%20Dey%20AK.%20et%20al.%20SenNet%20recommendations%20for%20detecting%20senescent%20cells%20in%20different%20tissues.%20Nat%20Rev%20Mol%20Cell%20Biol.%202024;25:1001%E2%80%931023." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Saul D, Kosinsky RL, Atkinson EJ, Doolittle ML, Zhang X, LeBrasseur NK, et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nature Commun. 2022;13:4827.
</cite> [<a href="https://doi.org/10.1038/s41467-022-32552-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9381717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35974106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saul%20D,%20Kosinsky%20RL,%20Atkinson%20EJ,%20Doolittle%20ML,%20Zhang%20X,%20LeBrasseur%20NK,%20et%20al.%20A%20new%20gene%20set%20identifies%20senescent%20cells%20and%20predicts%20senescence-associated%20pathways%20across%20tissues.%20Nature%20Commun.%202022;13:4827." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Jochems F, Thijssen B, De Conti G, Jansen R, Pogacar Z, Groot K, et al. The cancer SENESCopedia: a delineation of cancer cell senescence. Cell Rep. 2021;36. 109441.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2021.109441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8333195/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34320349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jochems%20F,%20Thijssen%20B,%20De%20Conti%20G,%20Jansen%20R,%20Pogacar%20Z,%20Groot%20K,%20et%20al.%20The%20cancer%20SENESCopedia:%20a%20delineation%20of%20cancer%20cell%20senescence.%20Cell%20Rep.%202021;36.%20109441." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008;27:5975–87.
</cite> [<a href="https://doi.org/10.1038/onc.2008.213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3843241/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18711403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fridman%20AL,%20Tainsky%20MA.%20Critical%20pathways%20in%20cellular%20senescence%20and%20immortalization%20revealed%20by%20gene%20expression%20profiling.%20Oncogene.%202008;27:5975%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Casella G, Munk R, Kim KM, Piao Y, De S, Abdelmohsen K, et al. Transcriptome signature of cellular senescence. Nucleic Acids Res. 2019;47:7294–305.
</cite> [<a href="https://doi.org/10.1093/nar/gkz555" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6698740/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31251810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Casella%20G,%20Munk%20R,%20Kim%20KM,%20Piao%20Y,%20De%20S,%20Abdelmohsen%20K,%20et%20al.%20Transcriptome%20signature%20of%20cellular%20senescence.%20Nucleic%20Acids%20Res.%202019;47:7294%E2%80%93305." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Joruiz SM, Von Muhlinen N, Horikawa I, Gilbert MR, Harris CC. Distinct functions of wild-type and R273H mutant Δ133p53α differentially regulate glioblastoma aggressiveness and therapy-induced senescence. Cell Death Dis. 2024;15:454.
</cite> [<a href="https://doi.org/10.1038/s41419-024-06769-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11211456/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38937431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Joruiz%20SM,%20Von%20Muhlinen%20N,%20Horikawa%20I,%20Gilbert%20MR,%20Harris%20CC.%20Distinct%20functions%20of%20wild-type%20and%20R273H%20mutant%20%CE%94133p53%CE%B1%20differentially%20regulate%20glioblastoma%20aggressiveness%20and%20therapy-induced%20senescence.%20Cell%20Death%20Dis.%202024;15:454." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Ann Rev Pathol. 2010;5:99–118.
</cite> [<a href="https://doi.org/10.1146/annurev-pathol-121808-102144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4166495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20078217/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Copp%C3%A9%20JP,%20Desprez%20PY,%20Krtolica%20A,%20Campisi%20J.%20The%20senescence-associated%20secretory%20phenotype:%20the%20dark%20side%20of%20tumor%20suppression.%20Ann%20Rev%20Pathol.%202010;5:99%E2%80%93118." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Faget DV, Ren Q, Stewart SA. Unmasking senescence: context-dependent effects of SASP in cancer. Nat Rev Cancer. 2019;19:439–53.
</cite> [<a href="https://doi.org/10.1038/s41568-019-0156-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31235879/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Faget%20DV,%20Ren%20Q,%20Stewart%20SA.%20Unmasking%20senescence:%20context-dependent%20effects%20of%20SASP%20in%20cancer.%20Nat%20Rev%20Cancer.%202019;19:439%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417–25.
</cite> [<a href="https://doi.org/10.1016/j.cels.2015.12.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4707969/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26771021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liberzon%20A,%20Birger%20C,%20Thorvaldsd%C3%B3ttir%20H,%20Ghandi%20M,%20Mesirov%20JP,%20Tamayo%20P.%20The%20molecular%20signatures%20database%20(MSigDB)%20hallmark%20gene%20set%20collection.%20Cell%20Syst.%202015;1:417%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Kristensen BW, Priesterbach-Ackley LP, Petersen JK, Wesseling P. Molecular pathology of tumors of the central nervous system. Ann Oncol. 2019;30:1265–78.
</cite> [<a href="https://doi.org/10.1093/annonc/mdz164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6683853/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31124566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kristensen%20BW,%20Priesterbach-Ackley%20LP,%20Petersen%20JK,%20Wesseling%20P.%20Molecular%20pathology%20of%20tumors%20of%20the%20central%20nervous%20system.%20Ann%20Oncol.%202019;30:1265%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics (Oxf, Engl). 2010;26:1572–3.</cite> [<a href="https://doi.org/10.1093/bioinformatics/btq170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2881355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20427518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wilkerson%20MD,%20Hayes%20DN.%20ConsensusClusterPlus:%20a%20class%20discovery%20tool%20with%20confidence%20assessments%20and%20item%20tracking.%20Bioinformatics%20(Oxf,%20Engl).%202010;26:1572%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Nowak B, Rogujski P, Janowski M, Lukomska B, Andrzejewska A. Mesenchymal stem cells in glioblastoma therapy and progression: how one cell does it all. Biochim Biophys Acta Rev Cancer. 2021;1876:188582.
</cite> [<a href="https://doi.org/10.1016/j.bbcan.2021.188582" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34144129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nowak%20B,%20Rogujski%20P,%20Janowski%20M,%20Lukomska%20B,%20Andrzejewska%20A.%20Mesenchymal%20stem%20cells%20in%20glioblastoma%20therapy%20and%20progression:%20how%20one%20cell%20does%20it%20all.%20Biochim%20Biophys%20Acta%20Rev%20Cancer.%202021;1876:188582." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Zhang C, Cheng W, Ren X, Wang Z, Liu X, Li G, et al. Tumor purity as an underlying key factor in glioma. Clin Cancer Res. 2017;23:6279–91.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-16-2598" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28754819/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20C,%20Cheng%20W,%20Ren%20X,%20Wang%20Z,%20Liu%20X,%20Li%20G,%20et%20al.%20Tumor%20purity%20as%20an%20underlying%20key%20factor%20in%20glioma.%20Clin%20Cancer%20Res.%202017;23:6279%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Zhu Y, Yao S, Chen L. Cell surface signaling molecules in the control of immune responses: a tide model. Immunity. 2011;34:466–78.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2011.04.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3176719/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21511182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20Y,%20Yao%20S,%20Chen%20L.%20Cell%20surface%20signaling%20molecules%20in%20the%20control%20of%20immune%20responses:%20a%20tide%20model.%20Immunity.%202011;34:466%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Uehara S, Yasuda M, Higuchi Y, Yoneda N, Kawai K, Suzuki M, et al. SGX523 causes renal toxicity through aldehyde oxidase-mediated less-soluble metabolite formation in chimeric mice with humanized livers. Toxicol Lett. 2023;388:48–55.
</cite> [<a href="https://doi.org/10.1016/j.toxlet.2023.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37806366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Uehara%20S,%20Yasuda%20M,%20Higuchi%20Y,%20Yoneda%20N,%20Kawai%20K,%20Suzuki%20M,%20et%20al.%20SGX523%20causes%20renal%20toxicity%20through%20aldehyde%20oxidase-mediated%20less-soluble%20metabolite%20formation%20in%20chimeric%20mice%20with%20humanized%20livers.%20Toxicol%20Lett.%202023;388:48%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Lilja S, Oldenburg J, Pointner A, Dewald L, Lerch M, Hippe B, et al. Epigallocatechin gallate effectively affects senescence and anti-SASP via SIRT3 in 3T3-L1 preadipocytes in comparison with other bioactive substances. Oxid Med Cell Longev. 2020;2020:4793125.
</cite> [<a href="https://doi.org/10.1155/2020/4793125" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7603628/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33149809/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lilja%20S,%20Oldenburg%20J,%20Pointner%20A,%20Dewald%20L,%20Lerch%20M,%20Hippe%20B,%20et%20al.%20Epigallocatechin%20gallate%20effectively%20affects%20senescence%20and%20anti-SASP%20via%20SIRT3%20in%203T3-L1%20preadipocytes%20in%20comparison%20with%20other%20bioactive%20substances.%20Oxid%20Med%20Cell%20Longev.%202020;2020:4793125." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Xu M, Tchkonia T, Ding H, Ogrodnik M, Lubbers ER, Pirtskhalava T, et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc Natl Acad Sci USA. 2015;112:E6301–10.
</cite> [<a href="https://doi.org/10.1073/pnas.1515386112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4655580/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26578790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20M,%20Tchkonia%20T,%20Ding%20H,%20Ogrodnik%20M,%20Lubbers%20ER,%20Pirtskhalava%20T,%20et%20al.%20JAK%20inhibition%20alleviates%20the%20cellular%20senescence-associated%20secretory%20phenotype%20and%20frailty%20in%20old%20age.%20Proc%20Natl%20Acad%20Sci%20USA.%202015;112:E6301%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Herranz N, Gallage S, Mellone M, Wuestefeld T, Klotz S, Hanley CJ, et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol. 2015;17:1205–17.
</cite> [<a href="https://doi.org/10.1038/ncb3225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4589897/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26280535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Herranz%20N,%20Gallage%20S,%20Mellone%20M,%20Wuestefeld%20T,%20Klotz%20S,%20Hanley%20CJ,%20et%20al.%20mTOR%20regulates%20MAPKAPK2%20translation%20to%20control%20the%20senescence-associated%20secretory%20phenotype.%20Nat%20Cell%20Biol.%202015;17:1205%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, et al. Oncogenic signaling pathways in the Cancer Genome Atlas. Cell. 2018;173:321–37.e10.
</cite> [<a href="https://doi.org/10.1016/j.cell.2018.03.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6070353/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29625050/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sanchez-Vega%20F,%20Mina%20M,%20Armenia%20J,%20Chatila%20WK,%20Luna%20A,%20La%20KC,%20et%20al.%20Oncogenic%20signaling%20pathways%20in%20the%20Cancer%20Genome%20Atlas.%20Cell.%202018;173:321%E2%80%9337.e10." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet. 2019;51:202–6.
</cite> [<a href="https://doi.org/10.1038/s41588-018-0312-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6365097/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30643254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Samstein%20RM,%20Lee%20CH,%20Shoushtari%20AN,%20Hellmann%20MD,%20Shen%20R,%20Janjigian%20YY,%20et%20al.%20Tumor%20mutational%20load%20predicts%20survival%20after%20immunotherapy%20across%20multiple%20cancer%20types.%20Nat%20Genet.%202019;51:202%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell. 2017;168:542.
</cite> [<a href="https://doi.org/10.1016/j.cell.2017.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28129544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hugo%20W,%20Zaretsky%20JM,%20Sun%20L,%20Song%20C,%20Moreno%20BH,%20Hu-Lieskovan%20S,%20et%20al.%20Genomic%20and%20transcriptomic%20features%20of%20response%20to%20anti-PD-1%20therapy%20in%20metastatic%20melanoma.%20Cell.%202017;168:542." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Agarwal Y, Milling LE, Chang JYH, Santollani L, Sheen A, Lutz EA, et al. Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity. Nat Biomed Eng. 2022;6:129–43.
</cite> [<a href="https://doi.org/10.1038/s41551-021-00831-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9681025/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35013574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Agarwal%20Y,%20Milling%20LE,%20Chang%20JYH,%20Santollani%20L,%20Sheen%20A,%20Lutz%20EA,%20et%20al.%20Intratumourally%20injected%20alum-tethered%20cytokines%20elicit%20potent%20and%20safer%20local%20and%20systemic%20anticancer%20immunity.%20Nat%20Biomed%20Eng.%202022;6:129%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Shi H, Medler D, Wang J, Browning R, Liu A, Schneider S. et al. Suppression of melanoma by mice lacking MHC-II: Mechanisms and implications for cancer immunotherapy. J Exp Med. 2024;221:e20240797
</cite> [<a href="https://doi.org/10.1084/jem.20240797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11528124/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39470607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi%20H,%20Medler%20D,%20Wang%20J,%20Browning%20R,%20Liu%20A,%20Schneider%20S.%20et%20al.%20Suppression%20of%20melanoma%20by%20mice%20lacking%20MHC-II:%20Mechanisms%20and%20implications%20for%20cancer%20immunotherapy.%20J%20Exp%20Med.%202024;221:e20240797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Sidhom EH, Kim C, Kost-Alimova M, Ting MT, Keller K, Avila-Pacheco J. et al. Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease. J Clin Invest. 2021;131:e141380
</cite> [<a href="https://doi.org/10.1172/JCI141380" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7919729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33444290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sidhom%20EH,%20Kim%20C,%20Kost-Alimova%20M,%20Ting%20MT,%20Keller%20K,%20Avila-Pacheco%20J.%20et%20al.%20Targeting%20a%20Braf/Mapk%20pathway%20rescues%20podocyte%20lipid%20peroxidation%20in%20CoQ-deficiency%20kidney%20disease.%20J%20Clin%20Invest.%202021;131:e141380" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Wong H, Belvin M, Herter S, Hoeflich KP, Murray LJ, Wong L. et al. Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacy. J Pharmacol Exp Ther. 2009;329:360–7.
</cite> [<a href="https://doi.org/10.1124/jpet.108.148189" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19147858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wong%20H,%20Belvin%20M,%20Herter%20S,%20Hoeflich%20KP,%20Murray%20LJ,%20Wong%20L.%20et%20al.%20Pharmacodynamics%20of%202-%5B4-%5B(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl%5D-3-(pyridine-4-yl)-1H-pyrazol-1-yl%5Dethan-1-ol%20(GDC-0879),%20a%20potent%20and%20selective%20B-Raf%20kinase%20inhibitor:%20understanding%20relationships%20between%20systemic%20concentrations,%20phosphorylated%20mitogen-activated%20protein%20kinase%20kinase%201%20inhibition,%20and%20efficacy.%20J%20Pharmacol%20Exp%20Ther.%202009;329:360%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Kim EH. Tumor treating fields induced senescence on glioblastoma. Am J Cancer Res. 2023;13:5626–40.
</cite> [<a href="/articles/PMC10695807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38058802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20EH.%20Tumor%20treating%20fields%20induced%20senescence%20on%20glioblastoma.%20Am%20J%20Cancer%20Res.%202023;13:5626%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Zhou Z, Wei J, Jiang W. Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas. Sci Rep. 2022;12:5457.
</cite> [<a href="https://doi.org/10.1038/s41598-022-09549-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8971489/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35361903/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20Z,%20Wei%20J,%20Jiang%20W.%20Characterization%20of%20aging%20tumor%20microenvironment%20with%20drawing%20implications%20in%20predicting%20the%20prognosis%20and%20immunotherapy%20response%20in%20low-grade%20gliomas.%20Sci%20Rep.%202022;12:5457." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Li J, Wang J, Liu D, Tao C, Zhao J, Wang W. Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes. Front Immunol. 2022;13:1018942.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.1018942" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9633681/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36341390/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Wang%20J,%20Liu%20D,%20Tao%20C,%20Zhao%20J,%20Wang%20W.%20Establishment%20and%20validation%20of%20a%20novel%20prognostic%20model%20for%20lower-grade%20glioma%20based%20on%20senescence-related%20genes.%20Front%20Immunol.%202022;13:1018942." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Mu J, Gong J, Shi M, Zhang Y. Analysis and validation of aging-related genes in prognosis and immune function of glioblastoma. BMC Med Genomics. 2023;16:109.
</cite> [<a href="https://doi.org/10.1186/s12920-023-01538-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10197415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37208656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mu%20J,%20Gong%20J,%20Shi%20M,%20Zhang%20Y.%20Analysis%20and%20validation%20of%20aging-related%20genes%20in%20prognosis%20and%20immune%20function%20of%20glioblastoma.%20BMC%20Med%20Genomics.%202023;16:109." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Hoeflich KP, Herter S, Tien J, Wong L, Berry L, Chan J, et al. Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression. Cancer Res. 2009;69:3042–51.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-08-3563" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19276360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hoeflich%20KP,%20Herter%20S,%20Tien%20J,%20Wong%20L,%20Berry%20L,%20Chan%20J,%20et%20al.%20Antitumor%20efficacy%20of%20the%20novel%20RAF%20inhibitor%20GDC-0879%20is%20predicted%20by%20BRAFV600E%20mutational%20status%20and%20sustained%20extracellular%20signal-regulated%20kinase/mitogen-activated%20protein%20kinase%20pathway%20suppression.%20Cancer%20Res.%202009;69:3042%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Hatzivassiliou G, Song K, Yen I, Brandhuber BJ, Anderson DJ, Alvarado R, et al. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature. 2010;464:431–5.
</cite> [<a href="https://doi.org/10.1038/nature08833" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20130576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hatzivassiliou%20G,%20Song%20K,%20Yen%20I,%20Brandhuber%20BJ,%20Anderson%20DJ,%20Alvarado%20R,%20et%20al.%20RAF%20inhibitors%20prime%20wild-type%20RAF%20to%20activate%20the%20MAPK%20pathway%20and%20enhance%20growth.%20Nature.%202010;464:431%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Maurer G, Tarkowski B, Baccarini M. Raf kinases in cancer-roles and therapeutic opportunities. Oncogene. 2011;30:3477–88.
</cite> [<a href="https://doi.org/10.1038/onc.2011.160" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21577205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maurer%20G,%20Tarkowski%20B,%20Baccarini%20M.%20Raf%20kinases%20in%20cancer-roles%20and%20therapeutic%20opportunities.%20Oncogene.%202011;30:3477%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Zhu H, Blake S, Kusuma FK, Pearson RB, Kang J, Chan KT. Oncogene-induced senescence: from biology to therapy. Mech Ageing Dev. 2020;187:111229.
</cite> [<a href="https://doi.org/10.1016/j.mad.2020.111229" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32171687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20H,%20Blake%20S,%20Kusuma%20FK,%20Pearson%20RB,%20Kang%20J,%20Chan%20KT.%20Oncogene-induced%20senescence:%20from%20biology%20to%20therapy.%20Mech%20Ageing%20Dev.%202020;187:111229." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12334699/bin/41419_2025_7915_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary figures</a><sup> (12.2MB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12334699/bin/41419_2025_7915_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary tables</a><sup> (419.2KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12334699/bin/41419_2025_7915_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Original File of Western Blot</a><sup> (1.2MB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cell Death &amp; Disease are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41419-025-07915-3"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41419_2025_Article_7915.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (11.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12334699/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12334699/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334699%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334699/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12334699/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12334699/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40781221/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12334699/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40781221/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12334699/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12334699/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="tVUXXXkmxTZZBV95zJKD4pd0nBrPHMgeoAlmwAFs4SIsGiTIuSrU44DrnNjM4fRE">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
